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Abstract 
 
Aging and obesity are two major aspects that can negatively impact musculoskeletal 
structure and function. It is important to study these aspects because of current high rates 
of obesity and the increasing proportion of seniors in North America. This study 
investigated the effects of a long-term high fat and sucrose diet (HFS) superimposed with 
aging on bone and muscle structure and function. Male C57BL/6J mice were randomized 
1 of 2 diets: control (AGE, AIN93M, 10.3% kcal fat, 100 g/kg sucrose) or HFS (HFS-
AGE, 45.3% kcal fat 200 g/kg sucrose) for 13 weeks starting at 20 weeks of age to 
represent middle age. Trabecular bone structure and volumetric bone mineral density 
(vBMD), body composition, and grip strength were measured longitudinally at 20, 24, 
28, and 32 weeks of age. In vitro contractile measures were performed on isolated soleus 
and extensor digitorum longus (EDL) muscles at baseline (BSL, 20 weeks of age, n=11) 
and at the end of the 13-week intervention when AGE (n=12) and HFS-AGE (n=12) mice 
were 33 weeks of age. Both the AGE and HFS-AGE groups had similar declines in 
trabecular bone (bone structure and vBMD). For muscle contractile function, HFS+AGE 
resulted in increased soleus cross-sectional area (CSA) compared AGE (p=0.0008), but 
this did not translate to greater twitch or tetanus peak force. The ratio of outcomes of 
bone to muscle declined in both the AGE and HFS-AGE groups as a result of a greater 
decline in key measures of bone structure (BV/TV) than muscle function (soleus and 
EDL peak tetanus and CSA) and was not altered by feeding HFS. In conclusion, 
beginning a HFS diet during middle age did not exacerbate age-related declines in bone 
or muscle, but these tissues do not decline in a coordinate manner with aging as bone 
structure declined at a greater rate than muscle function. 
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Chapter 1: Introduction 
The musculoskeletal system is comprised mainly of bone and skeletal muscle. In 
combination, this is what protects the vital organs and supports and moves the body. 
When this system becomes compromised it can potentially impact an individuals’ 
mobility, quality of life, daily living, and work [1]. Musculoskeletal diseases, which 
include osteoporosis, osteoarthritis, rheumatoid arthritis and spinal disorders, are the most 
common cause of chronic disability worldwide. The prevalence of these diseases increase 
with age [2]. With aging, bone is weakened and is increasingly prone to fragility fractures 
[3] and there is also concomitant loss in muscle mass and function [4]. Thus, both tissues 
are compromised with aging, albeit some individuals are more susceptible than others due 
to risk factors that include genetic predisposition as well as a variety of lifestyle factors. 
In Canada, as of the year 2000, musculoskeletal diseases cost taxpayers $22.3 billion, 
making it the most expensive of any group of diseases [5].  
In addition to aging, obesity and its associated diseases such as type II diabetes, 
cardiovascular disease, and bone degeneration are becoming more prevalent, making 
studying the effects of diet-induced obesity of great interest. The combination of 
inactivity and the typical Western diet, which is high in saturated fat and refined sugars 
[6], are the main contributors to obesity [7]. Currently, it is well established that obesity 
is detrimental to health, however the mechanisms behind the effects of inactivity and a 
high fat and sugar diet (HFS) on the musculoskeletal system, more specifically how a 
HFS affects bone and muscle structure and function, remains poorly understood.  
The relationship between bone and muscle is a developing area of research, with an 
increasing interest in muscle-bone “crosstalk” [8, 9]. This muscle-bone “crosstalk” is a 
new term used to describe the interaction of bone and muscle and the how each affects 
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the other’s ability to function optimally. This interaction has more recently been 
suggested to have a biochemical component with muscle acting as an endocrine organ 
releasing growth factors and cytokines that target bone, however the biochemical 
influence of bone on muscle is less well established [8, 10, 11]. This interaction also 
includes an established physical relationship with muscle acting as a primary mechanical 
force on bone [12], which will be the focus of this thesis. For example, bone and muscle 
tissue mass are closely associated throughout the lifetime, with aging, chronic exercise, 
and disuse [8]. Since Canada has an aging population [13], in combination with 
increasing obesity rates [7], the combined effects of diet induced obesity with aging on 
the musculoskeletal system is an important area of research. The superimposition of these 
two factors has not been well studied, even though the effects of diet-induced obesity or 
aging on bone or muscle have been studied separately using animal models [3, 14-20]. 
This thesis examines the effects of aging and aging superimposed with a HFS, on bone 
and muscle structure and function. More specifically, body composition, volumetric bone 
mineral density (vBMD), bone structure, and grip strength were measured longitudinally, 
and muscle contractile function and muscle fibre typing, were analyzed as endpoint 
measures. To analyze alterations in the ratio of bone to muscle structure and function, 
both proximal tibia bone structure (bone volume/total volume, BV/TV) and bone mineral 
density (BMD) were used, while peak tetanus force and cross-sectional area (CSA) for 
the soleus and EDL served as measures for muscle function and size.  	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Chapter 2: Literature Review 
Bone 
Structure and Function 
Bone functions to support the body, enable movement, and protect various organs. To 
carry out these functions bone presents an interesting dichotomy. It must be stiff to resist 
deformation to allow for loading, but flexible to absorb force and light to allow for ease 
of movement yet strong to allow for loading without fracture [21]. The composition of 
bone allows for this dichotomy, which includes mainly type I collagen for elasticity and 
calcium hydroxyapatite ([Ca10(PO4)6(OH)2]) for stiffness [21, 22].  
There are two main structural types of bone, known as cortical and trabecular bone. 
Cortical bone is very dense with a low turnover rate and contains osteocytes, canaliculi, 
and blood vessels. Trabecular bone is porous, and typically described as a network of 
boney struts, and it is known to have a high turnover rate for remodeling [22]. Trabecular 
thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp) are used 
to measure and quantify trabecular bone. These measures of trabecular bone characterize 
the overall percentage of bone volume to total volume within a region of interest 
(BV/TV) [23]. For example, decreased Tb.Th and Tb.N and increased Tb.Sp would result 
in an overall decrease in BV/TV; it is the combination of these measures that contributes 
to overall percent bone volume. Therefore, it is the bone geometry (size and shape) and 
structure (trabecular architecture and cortical thickness) that play a role in the structural 
properties associated with the strength of bone [24]. It is the combination of bone 
quantity measured as the amount of BMD, and quality, measured as bone geometry and 
structure that determines overall bone strength [25].  
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In addition to their structural properties, bones are classified into three main groups: 
flat (i.e., bones of the skull), short (i.e., carpal bones and vertebral bodies), and long (i.e., 
tibia, femur, and humerus) [25]. Unique to long bones is the medullary cavity which 
houses bone marrow [21]. Aside from erythrocyte production, bone marrow is important 
as the site where both osteoblast (responsible bone formation) and osteoclast (responsible 
for bone resorption) cells originate. Osteoblasts and osteoclasts are involved in bone 
turnover and remodeling and the ratio of their activities determines whether there is 
overall bone formation or resorption.  
The maximum quantity of bone over the lifespan, achieved following the growth 
period in early adulthood, is known as the peak bone mass [26]. Maximizing peak bone 
mass is considered important as it is believed to set a trajectory for a skeleton that is less 
prone to fragility fractures as a consequence of the loss of BMD and structure that often 
occurs during aging [26]. Male C57BL/6J mice were selected for this thesis research 
since they do not have the loss of estrogen with aging like females, which accounts for a 
decline in bone [27] and could confound the effects of aging and diet-induced obesity. In 
addition, the C57BL/6J mouse strain is vulnerable to diet-induced obesity and is a good 
model of the human metabolic syndrome [28]. The proximal tibia was analyzed since it is 
a skeletal site that contains a high proportion of trabecular bone, known to be responsive 
to modifiable lifestyle factors, such as diet [29].  Depending on the composition, diet 
during early life can have positive or negative effects on bone development and, 
ultimately, the attainment of peak bone mass [29]. The focus of this study is examining if 
an obesogenic diet (HFS) exacerbates the negative effect of aging alone on bone structure 
and function. 
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Dietary Considerations for Bone Health  
 Nutrition is an important factor in the development, remodeling, and maintenance 
of bone. Essential nutrients for bone include a variety of micronutrients (calcium, 
phosphorus, vitamin D) and macronutrients (protein, essential fatty acids) [30-35].  
Micronutrients: Calcium, Phosphate, Vitamin D 
Calcium and phosphate are important since these minerals compose 80-90% of 
bone mineral content mainly in the form of hydroxyapatite [30]. Bones contain 
approximately 99% and 80% of the calcium and phosphate in the body, respectively [36]. 
Adequate calcium intake is important during growth for normal bone development in 
both rodents [37] and humans [38, 39] and remains an important nutrient with aging for 
the maintenance of bone in both rodents [40] and humans [41, 42]. Calcium and 
phosphate not only play a structural role in bone, but also influence bone formation and 
resorption through direct influences on osteoblasts and osteoclasts. Phosphate inhibits the 
differentiation of osteoclasts and stimulates mature osteoclast apoptosis [43, 44], while, 
calcium stimulates the proliferation and differentiation of osteoblasts and inhibits 
osteoclastogenesis [45]. But calcium and phosphate intake must be in the presence of 
adequate levels of vitamin D. 
Vitamin D influences calcium and phosphate metabolism at the intestine 
(absorption), kidneys (resorption), and bone (indirect and direct affects). Specifically, it is 
the active metabolite of vitamin D, 1,25-dihydroxyvitamin D, which has an effect on 
these target organs [30]. There are two ways of obtaining vitamin D, which include skin 
exposure to sunlight and through the diet, consumption of vitamin D2 and D3 - differing 
only in their side chains [46]. Vitamin D status can be compromised during aging through 
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several mechanisms: less sun exposure; attenuated de novo synthesis of vitamin D; lower 
intake of vitamin D; and sequestration in fat tissue due to higher fat mass that 
accompanies aging [47], [48]. Thus, bioavailability of vitamin D decreases with obesity 
[49-52]. Since lard was the fat source in the experimental diets used in this thesis, it was 
important to test for vitamin D content to ensure the experimental group was not 
receiving excess vitamin D. Aside from vitamin D, other vitamins that play a role in bone 
health include vitamins A, C, E, K and B vitamins and other essential micronutrients for 
bone health include magnesium, phosphorus, potassium, fluoride, copper, iron, zinc, and 
manganese [30, 32, 33]. Therefore, to be able to study the effects of dietary fat content on 
the rate of bone decline with aging, nutrients (especially calcium, phosphate, and vitamin 
D) were kept consistent in the experimental diet (HFS) compared to the control diet on 
the basis of energy so that only the effects of the high fat diet were studied.  
Macronutrients: Protein and Fat 
Protein is an important macronutrient for BMD, structure, and strength, as 
reviewed by [34, 35]. Deficient dietary protein results in the development of osteoporosis 
in aged male rats (8 months of age, 1 or 7 month diet) with thinning of trabecular and 
cortical bone and decreased bone strength [53]. Adequate dietary protein is essential for 
maintaining bone health, especially since low protein intake is associated with an 
increased risk of hip fractures in the elderly men and women [34].  
In addition to protein, dietary fats are also an important macronutrient for bone 
health. However, dietary fats are not all equal, some fats are essential for optimal bone 
health while others can be considered detrimental. Since the body cannot produce 
unsaturated fatty acids with a double bond in the first nine carbons, these are known as 
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essential fats that must be consumed in the diet, which include n-3, α-linolenic acid, 
which can be converted to eicosapentaenoic acid and docosahexaenoic acid and n-6, 
linolenic acid, which can be converted to arachidonic acid, as reviewed by [54]. Other 
fats, such as trans and saturated fats, are considered unhealthy for bone development [55]. 
The effects of a high fat will be further discussed in the following sections.  
Bone Remodeling 
Bone is a dynamic tissue that is constantly being turned over, with the ability to 
adapt its shape and size in response to mechanical loads. The process of adding and 
removing bone is known as bone remodeling, which is mediated by osteoblasts and 
osteoclasts (responsible for bone formation and resorption, respectively), and osteocytes 
(responsible for sensing bone deformation), and is modulated by hormones, cytokines, 
and mechanical stimuli [56]. Bone remodeling is a continuous process throughout the 
lifespan with greater bone formation during growth and development, followed by a 
maintenance period during middle age, and bone resorption with aging [3]. It is the 
balance between the osteoblast and osteoclast activity that determine the rate of 
remodeling and whether there is overall bone formation or resorption at any given time. 
Control of osteoblast and osteoclast activity is a result of multiple factors including 
hormones, growth factors, and cytokines [57]. These bone cells are derived from different 
progenitor cells, and differ in their molecular control mechanisms.  
Osteoblasts are derived from mesenchymal stem cells, which can also 
differentiate into adipocytes, chondrocytes, or myoblasts [56]. In the presence of runt-
related transcription factor 2 (Runx2), mesenchymal stem cells will become 
preosteoblasts and further differentiate to functional osteoblasts in the presence of the 
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transcription factor osterix [58, 59]. Some osteoblasts become encased in the bone matrix 
and become osteocytes, which play a role in regulating both osteoblast and osteoclasts 
activity and sense bone deformation with mechanical stimuli, sending the signal for bone 
remodeling [60, 61]. However, certain transcription factors, such as leptin can shift the 
differentiation of mesenchymal stem cells to osteoblastogenesis [62] and in contrast 
peroxisome proliferator-activated receptor gamma (PPARγ), can shift the mesenchymal 
differentiation to adipogenesis, creating fat cells rather than osteoblasts [63, 64]. 
In contrast to osteoblasts, the osteoclasts are derived from granulocyte-macrophage 
lineage of hematopoietic stem cells, and can also differentiate into monocytes or 
macrophages [57]. To differentiate into osteoclasts, the hematopoietic stem cells must 
first be exposed to macrophage colony-stimulating factor, secreted by osteoblasts, to 
become preosteoclasts. Following which, receptor activator of nuclear factor- κB 
(RANK) receptor on the preosteoclasts either directly associates with RANK-ligand 
(RANKL) found on the osteoblast membrane or is activated by soluble RANKL secreted 
from osteoblasts. It is this binding between RANK and RANKL that activates osteoclasts 
and further promotes osteoclastogenesis and inhibits osteoclast apoptosis [65]. Therefore, 
osteoblasts and osteoclasts are integrally linked for bone remodeling. The differentiation 
of osteoblasts, osteoclasts, and bone remodeling is directly and indirectly affected by both 
nutrition and aging. 	  
Bone and Obesity 
There is an association between body mass and BMD based on the established 
relationship between mechanical loading and bone formation, as explained by the 
mechanostat theory [19]. The mechanostat theory states that mechanical usage is 
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translated into signals that determine bone remodeling to fit bone mass to the load placed 
on the bone [12]. Since the body cannot distinguish the gravitational forces exerted from 
lean mass or fat mass, obesity has traditionally been considered to have a positive effect 
on bone [66, 67]. However, fractures in obese postmenopausal women and older men 
make up a significant proportion of overall fragility fractures and it is suggested that 
obese individuals are at a greater risk for certain types of fractures. Specifically, 
postmenopausal women are at a greater risk of ankle, upper leg, proximal humerus, and 
vertebral fractures, while men are at a greater risk of rib, nonvertebral, and hip fractures, 
as reviewed by [18]. This may be due to metabolic disturbances, such as impaired 
glucose tolerance, as well as differences in how obese versus non-obese individuals fall 
and fat distribution acting as padding around certain sites [18].  
A higher body mass index (BMI), calculated by expressing body mass (kg) per 
body height (m2), is associated with a greater BMD [68]. This is considered protective 
against fragility fractures in humans, but studies remain inconclusive with evidence 
suggesting beneficial, detrimental, or no effect of a greater BMI on fracture risk [68-70]. 
The relationship between BMI and fracture risk is complex with discrepancies based on 
skeletal sites measured and assessment of fracture risk with or without a correction for 
body weight. A large proportion of research examining the relationship between obesity 
and osteoporosis has not accounted for mechanical loading caused by greater body 
weight. When bone mass is adjusted for body weight, the mechanical loading effect on 
bone is removed and in Chinese and Caucasian subjects it is suggested that the 
correlation between fat mass and bone mass becomes negative [71]. Whereas, body 
composition goes beyond calculated BMI by distinguishing alteration in relative lean, fat, 
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and bone mass. Diet induced-obesity increases relative fat mass and decreases lean mass 
[72]. This relationship between a greater BMD and fractures within an obese population 
presents a potentially interesting dichotomy.  
It has become increasingly apparent that this is not a simple relationship and there 
are mechanisms beyond just mechanical loading [73]. Aside from the direct mechanical 
load from body weight, obesity may affect bone metabolism through multiple different 
mechanisms and pathways. Thus, it is suggested that there are competing effects of 
mechanical loading inferred from body weight and adiposity negatively altering bone 
metabolism in the cumulative effects on bone structure and function. 
Effects of Diet-Induced Obesity on Bone Structure and Strength 
Although dietary fat is essential for life, the effects of a high fat diet on bone 
quality and composition vary based on the source of fat. Bone is highly responsive to 
dietary fats with the source of the fatty acids reflected in the bone lipid composition [74-
76]. However, the role of altered bone lipid composition on bone strength and/or structure 
remains unclear [75-77]. Diet interventions that use polyunsaturated fatty acids, 
specifically long chain n-3 fatty acids, appear to have beneficial effects on bone 
(reviewed in [31, 78-80]). While high-saturated fat diets, present in a typical Western 
diet, have shown detrimental effects [81-88], no effect [89], or even positive effects [72] 
on bone using mice and rats. 
Before discussing the specifics of the effects of diet-induced obesity on bone 
structure and strength, it is important to discuss differences in diet composition and 
reporting of diet composition. In particular, incomplete reporting of diet composition 
makes it particularly challenging to compare findings among studies. A high fat diet 
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(HFD) is generally defined as a diet with a 40% or greater kilocalories (kcal) from fat 
[72, 81-89]. While we know diet-induced obesity with a HFD can effectively be achieved 
by adding sucrose to the diet, many studies refer to a HFD and fail to include details of 
the diet composition, including whether sucrose was incorporated. Also, few studies 
report whether micronutrient composition was adjusted for the higher energy level 
present in a HFD or HFS. This has created confusion on the effects of diet-induced 
obesity on the musculoskeletal system. Some but not all rodent studies that feed a diet 
containing higher saturated fat without altering sucrose report heavier body weight as 
well as a higher fat mass. Therefore, this thesis defined diet-induced obesity as an 
increase in weight gain and/or fat mass with feeding a HFD or HFS. 
Studies that adequately report the details of the diet composition have found 
detrimental effects of high saturated fat and sucrose diets in mice (6 weeks of age) [81, 
82] and rats (4 weeks of age) [90], no effect in mice (10 weeks of age) [89], or even a 
positive effect in mice (12 weeks of age) [72]. However, other studies with limited 
information on diet composition without specification of the source of fat or addition of 
sucrose have also found detrimental effects of a HFD in mice (5-20 weeks of age) [85, 
86] and rats (4 weeks of age) [87]. As previously mentioned, saturated fats during early 
growth and development negatively affect bone growth by reducing the peak bone mass 
[55]. A majority of studies investigating the effects of diet-induced obesity on bone in 
mice and rat models have either begun during growth and development [76, 81, 82, 84-
87, 90], and/or the diets have been short term [86, 87]. It is suggested that diet-induced 
obesity is more detrimental in developing rodent models than adult rodent models [85]. 
However, there are limited studies investigating effects of diet induced obesity at middle 
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age through aging, a life stage when structure and function of bone is declining [3].  
Bone is considered a less metabolically active tissue than muscle; nevertheless, 
some studies using only a short duration (4 weeks) high fat diet (66% or 94.5% kcal fat) 
can elicit negative changes in young rats (4 weeks of age) on bone outcomes (BMD, 
structure, and strength), partially explained by reductions in bone formation markers [87]. 
Feeding HFS more adversely affect trabecular bone than cortical bone in male mice (6 
weeks of age), measured using µCT [81, 82]. The detrimental structural changes with 
diet-induced obesity have been associated with a decrease in bone formation (osteocalcin) 
and increase in bone resorption (tartrate resistant acid phosphatase), measured by blood 
serum markers [82].  
In addition to the greater mechanical stimuli due to an increase body weight gain, 
there are changes in hormones and cytokines associated with an obesogenic diet. It 
appears that diet-induced obesity works in two opposing phases in bone in young adult 
mice (12 weeks of age) [72]. Chronic obesogenic diets lead to an increase in body weight 
and therefore greater mechanical loading on the bone, which is suggested to have a 
protective effect. However, there is also an increase in inflammatory cytokines, which 
have detrimental effects on bone remodeling rates. It has recently been hypothesized that 
diet-induced obesity may have mediated effects in an inverted ‘U’ shape, acting in two 
opposing phases. The initial phase characterized as beneficial effects on bone with 
increased mechanical load and a second phase that is detrimental with lower bone 
formation rates (Figure 2.1) [72]. This theory stemmed from a study using young adult 
(12 weeks old) male C57BL/6J mice on an 11-week HFS (45% kcal lard and 173g/kg 
sucrose). This two-phase hypothesis was suggested due to the positive effects on 
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trabecular bone structure between baseline and endpoint measures, but lower mineral 
apposition rates (i.e., lower bone formation) with the HFS suggesting potential 
detriments. To better understand this two-phase hypothesis a longer duration diet 
intervention or older animals should be studied. 
 Building off this hypothesis using this proposed model the literature suggests that 
diet-induced obesity would be detrimental to bone health during development in young 
animals and in old age during bone decline, but in young adult animals would result in 
positive effects on bone through the mechanostat theory. This age-related model would 
help explain some of the discrepancies seen between studies based on the age of animals 
examined during diet interventions. Although this dichotomy between high BMD and the 
increased incidence of fracture at certain skeletal sites in obese postmenopausal and older 
men has been documented [18], the effects on bone structure, geometry, and function in 
middle aged adults remains an active area of research. 
 
Figure 2.1. Hypothesized inverted ‘U’ shaped curve model for describing the effects of 
diet-induced obesity on bone. The solid line represents the improved trabecular bone 
structure, while the dotted line represents the suggested detriments of diet-induced 
obesity on bone structure based on a decrease in bone formation [72]. 
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Using this hypothesized inverted ‘U’ shaped curve model, we can examine how diet-
induced obesity affects bone and muscle differently throughout the lifespan. Differential 
results may be due to different phases in the life span, diet composition, and the duration 
of nutritional interventions. Young mice and rat models (3 to 7 weeks of age) are 
adversely affected by diet-induced obesity regardless of the diet duration (1 to 24 months) 
[81, 82, 84-88, 90], while in young adult mice appears to have a positive effect (11 week 
diet) [72], and diet-induced obesity over the lifespan has a negative affect [88, 90]. 
However, studies examining the effects of diet-induced obesity on bone have not 
included muscle measures and muscle-generated loads play a key role in bone size and 
structure [12]. Since bone and muscle are integrally linked and both are affected by diet-
induced obesity it is important to study these tissues in conjunction to better understand 
their relationship and how these tissues may affect one another.  
Effects of Diet-Induced Obesity on Negative Regulation of Bone Remodeling 
There are a number of possible mechanisms for negative changes in bone structure 
and function associated with diet-induced obesity. One suggested mechanism is the 
inverse relationship between adipocytes and osteoblasts, since they are both derived from 
mesenchymal stem cells. This competitive relationship between the differentiations of 
precursor cells to osteoblasts versus adipocytes translates into less osteoblast activity and 
bone formation [91].  
Another potential mechanism is related to changes in hormonal and cytokine 
signaling. Diet-induced obesity is associated with an increase in fat mass and a resultant 
increase in adipokines, chronic low-grade inflammation and resultant increase in 
proinflammatory cytokines, such as TNF-α and IL-6. Although bone remodeling may be 
	   	   15	  
positively influenced by adipokines such as leptin [62], proinflammatory cytokines 
stimulate osteoclast differentiation, survival, and as a result bone resorption [92, 93].  
Bone and Aging 
 Maintaining bone health throughout the lifespan is important because of the 
inevitable decline in bone and increased risk of fragility fracture with aging [3]. 
Modifiable lifestyle factors, such as nutrition, are important for bone health to slow the 
loss of BMD and strength, which increases the risk of a fragility fracture [27, 29]. 
Although osteoporosis is considered a disease associated with aging, it is a lifelong 
disease with geriatric consequences. This has earned the disease the name of “the silent 
thief” since significant losses in mineral and structure often occur with no symptoms. 
This increased bone loss is a not necessarily a result of aging alone, but a combination of 
factors, including 1) genetics, a strong predictor of bone health that cannot be altered, and 
2) lifestyle and nutrition choices throughout the life span, which are modifiable and can 
have both a positive or negative impact [27].  
Effects of Aging on Bone Structure and Function 
 There is a natural decline in BMD and bone structure with aging. However, the 
extent of this decline varies among individuals and understanding the mechanisms and 
factors that contribute to these alterations is an active area of research [3]. It is the decline 
in both bone quantity and quality that contributes to bone strength and thus overall risk of 
a fragility fracture [3]. Therefore, it is important to not only analyze bone quantity but 
also bone structure to have a better understanding of alterations in bone strength. 
In general, cortical bone becomes thinner, more brittle, and weaker with aging 
[94, 95], while trabecular bone struts also weaken [96]. This alteration in bone brittleness 
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with aging is due to changes in bone composition. Bones become more brittle as a result 
of a decrease in collagen content, resulting in a shift towards a higher bone mineral 
content and reduced elasticity [3]. The two other contributors to bone strength in addition 
to bone composition are bone quantity and structure. A comparison between young (5 
months) and aged (23 months) male rats highlights this decline in BMD, bone volume, 
and trabecular number with age at the proximal tibia [97]. Similarly, this has been 
demonstrated in separate studies using aged male C57BL/6J mice (20 and 24 months of 
age) with significant decreases in bone volume, as a result of decreased trabecular 
number and increase in trabecular separation with little change or even an increase in 
trabecular thickness. This decline in trabecular bone was observed to continuously 
decrease from approximately 1.5 to 24 months of age and from 1 to 20 months of age 
with an initial rapid decline in trabecular bone from 2 to 6 months of age in male mice 
[94, 98].  
The structural changes that occur in the trabecular and cortical bone, as well as the 
bone marrow are a result of alterations in osteoblast and osteoclast activity [14]. Bones 
are repetitively loaded, which causes micro-damage to the bone tissue. Normally this 
micro-damage allows for bone remodeling, however with aging there is an exponential 
increase in this micro-damage as seen in human bones [99]. It is suggested that there is an 
inability to repair these cracks [100], propagating this micro-damage and resulting in a 
decrease in trabecular and cortical bone strength [101]. This decrease in bone repair is a 
result of the relatively higher rates of bone resorption that exceed bone formation that 
also causes this decline in bone tissue. These alterations in bone remodeling with aging 
that result in structural changes are controlled by a number of signaling factors. Since 
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diet-induced obesity may further compromise bone with aging and given Canada’s aging 
population [13] and rising obesity rates [7], this makes for an important research area.  
Aging also highlights sex-related differences in bone loss. In trabecular bone, for 
men, bone loss is mainly a result of thinning of trabecular struts, while with women it is a 
decrease in trabecular connectivity [102]. Since osteoporosis is considered more of a 
women’s disease with 1 in 3 women compared to 1 and 5 men suffering an osteoporotic 
fracture in their lifetime [103], research examining aging and bone health is often female-
orientated. However, compromised bone is still a major health concern for men and sex-
related differences in aging make it important to understand how aging affects males 
differently from females.  
Effects of Aging on Negative Bone Remodeling 
There is a decrease in osteoblast activity and increase in osteoclast activity 
resulting in this age-associated bone loss. With aging the cellular activity of the bone 
marrow is altered [57], with mesenchymal stem cells differentiating more into adipocytes 
instead of osteoblasts, since osteoblast differentiation becomes suppressed with aging 
[64]. There is an overall decrease in the amount of bone deposition with each bone 
remodeling cycle [104]. Aging is also associated with the progressive inability to sense 
and respond to forces as a result of dysfunctional osteocytes [105]. In addition to this 
dysfunction, osteocyte apoptosis increases with aging, which contributes to bone 
weakness separate from BMD by filling in lacunae with mineralization causing a 
disruption in the lacunae system and increasing micro cracks [3]. Changes in bone 
structure and strength is a result of a combination of increased osteoclast activity, 
decreased osteoblast activity and differentiation, and apoptosis of osteocytes. Although 
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age-related decline in bone has been well characterized and diet induced obesity appears 
to be detrimental to young mice and rats this is only part of the equation since muscle 
forces play a key role in bone structure and strength. 
Skeletal Muscle 
Structure and Function 
Skeletal muscle allows for voluntary movement and exerts forces on bones. In 
terms of function, skeletal muscle can be viewed from both a mechanical and metabolic 
context. From a mechanical perspective, skeletal muscle generates forces to maintain 
posture and produce movement, while from a metabolic view it contributes to basal 
energy metabolism, heat production, and storage for substrates (e.g. amino acids, 
carbohydrates, and fat) [106]. It contributes approximately 40% to total body weight and 
is composed of mainly water (75%), protein (20%), and other substances including 
inorganic salts, minerals, fats, and carbohydrates (5%). Similar to bone metabolism, 
muscle mass depends on a balance between protein synthesis and degradation, both of 
which are sensitive to a variety of factors including nutrition, hormones, physical 
activity/exercise, and injury or disease [106]. The sensitivity of skeletal muscle to these 
factors and its dynamic nature make it one of the most plastic or adaptable tissues in the 
body.  
Structurally, muscle is organized into multiple compartments separated by layers 
of connective tissue with an organized arrangement of muscle fibres. The epimysium 
connective tissue encases the whole muscle, the perimysium encases bundles of muscle 
fibres, and the endomysium encases single muscle fibres. These single muscle fibres are 
composed of thousands of myofibrils that consist of a repeating unit known as the 
sarcomere, which is the basic contractile unit of skeletal muscle. It is the arrangement of 
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myofilaments that form the sarcomere, with the two most abundant myofilaments being 
actin and myosin [107].  
There are three main fibre types each with their own set of characteristics. These 
include type I slow twitch fibres, which rely heavily on oxidative energy production, have 
a relatively slow contraction and relaxation speed, and are fatigue resistant. Type II fibres 
can be subdivided into type IIa, type IIx, and type IIb, all of which are considered fast 
twitch and rely more on glycolytic energy production. Type IIa fibres rely on both 
oxidative and glycolytic energy production with a faster relative contraction and 
relaxation speed than type I fibres. While type IIx and IIb rely on glycolytic energy 
production with type IIx having a faster relative speed of contraction than type IIa. Type 
IIb is considered the fastest and most extreme fibre type, and is found almost exclusively 
in animal populations and not normally expressed to any great degree in human skeletal 
muscle [107]. It is the expression of isoforms of the myosin heavy chain (MHC) protein, 
the ‘motor’ of the thick filament, that in part determines the relative speed of contraction 
of a fibre [108]. The basic muscle fibre type characteristics have been summarized in 
Table 1.1. 
Table 1.1 Skeletal muscle fibre type characteristics. 
Fibre Type Contraction 
Speed 
Power 
Produced 
Resistance to 
Fatigue 
Energy 
production 
Type I slow low high aerobic 
Type IIa moderately fast medium intermediate aerobic/ 
anaerobic 
Type IIx fast high low anaerobic 
Type IIb very fast very high very low anaerobic 
Note. Type IIb fibres exclusively in animal populations. 
Muscle fibre type is commonly determined by staining muscle sections for the 
different MHC isoforms (also named MHC I, IIa, IIx and IIb). Studying these different 
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types of muscle fibres in murine models is beneficial since some of their muscles are 
homogenous, such as the soleus, which is predominantly composed of type I and type IIa 
fibres, and the EDL, which is predominantly composed of type II fibres [109]. Despite 
characterizing muscle fibres as distinct fibre types, recent immunohistochemical staining 
of both rodent and human muscle has indicated that muscle fibres can express two MHC 
isoforms, classifying these fibres as hybrids [110-113]. However, human skeletal muscle 
is more heterogeneous in nature, therefore there is not a direct comparison between 
rodents and humans [106]. But, rodent research provides valuable information on these 
individual fibre types because muscles such as the soleus and EDL can be chosen to 
represent the different contractile fibre types, since rodent muscles are more specialized 
and can contain high percentages of individual fibre types. The male C57BL/6J mouse 
model was selected for this thesis since the C57BL/6J mouse model is commonly used 
for muscle contractile function [114-117] and males do not have a loss of estrogen with 
aging like females, which could affect muscle function. Specifically the soleus and EDL 
were used to represent slow twitch and fast twitch muscles respectively, since these hind 
limb muscle are commonly isolated and incubated for contractile studies [114-117], and 
the fibre type composition of these muscles has been characterized (summarized in Table 
1.2) [110].  
Table 1.2. Soleus and EDL fibre type composition in C57BL/6J mice. 
 Type I Type 
I/IIa 
Type IIa Type 
IIa/IIx 
Type IIx Type 
IIa/IIb 
Type IIb 
Soleus 30.6% 0.6% 49.1% 4.4% 11.8% 0.5% 3.1% 
EDL 0% 0% 10.2% 3.6% 23.7% 6.8% 55.7% 
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Skeletal Muscle and Obesity 
 Obesity leads to an increase in ectopic fat accumulation in tissues such as liver 
and skeletal muscle, and this associated with the metabolic syndrome, a whole body 
disease. Because skeletal muscle, by virtue of its size, is an important player in whole 
body glucose homeostasis, the accumulation of ectopic fat in skeletal muscle is thought to 
play an important role in this disease. The metabolic syndrome is characterized by a 
reduced muscle glucose uptake and insulin sensitivity, mitochondrial dysfunction and 
lipotoxicity [118]. The accumulation of intramyocellular lipids, specifically toxic 
intermediates (e.g., ceramides and diglycerides) rather than intramuscular triglyceride 
storage, is thought to be associated with the development of muscle insulin resistance by 
interfering with normal intramyocellular signaling at several levels [20, 119]. Through 
this mechanism, diet-induced obesity also interferes with muscle protein synthesis 
resulting in reduced muscle mass [118]. However, the effects of ectopic fat infiltration in 
response to a long duration HFD differentially effects the slow and fast twitch muscle 
fibres, with predominantly fast twitch muscles (e.g., tibialis anterior, EDL) accumulating 
ectopic lipids, while predominantly slow twitch muscles (e.g., soleus) demonstrating no 
significant change in lipid accumulation [118]. This suggests that slow twitch muscles are 
protected from the detrimental effects of a HFD, while fast twitch muscles are not. This 
differential effect of a HFD on lipid accumulation is also associated with differential 
responses for muscle contractile function in response to HFS. These changes will be 
discussed more fully in the following sections. 
Effects of Diet-Induced Obesity on Skeletal Muscle 
It has been well documented that diet-induced obesity leads to an increase in 
intramuscular fat in both a high saturated fat (lard) and sucrose diet (31.5% kcal from fat) 
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similar to the Westernized diet [118] and an extremely high fat diet (60% kcal from fat) 
[117]. Current theory suggests that it is not the accumulation of neutral lipids, such as 
triglycerides in the muscle that are problematic, but rather the accumulation lipotoxic 
intermediates (e.g., ceramides and diacylglycerols) that often accompany muscle lipid 
uptake that negatively affect muscle signaling and function and this has been well studied 
(reviewed in [20, 119]). The effect of this ectopic fat accumulation on muscle contractile 
properties in different muscle types, fast twitch (e.g., EDL) versus slow twitch (e.g., 
soleus) is a newer area of research [116, 117, 120]. The effects of diet-induced obesity on 
contractile properties appear to be sex-specific, such that pre-menopausal females appear 
to be protected from diet-induced obesity decreases in muscle function. This is possibly 
because female mice have a greater number of type I fibres, compared to males [121]. 
Type I fibres rely more heavily on fat oxidation for energy, potentially protecting females 
from intramuscular lipotoxic fat accumulation and subsequent muscle dysfunction. In 
addition, male mice show a strong inverse relationship between the proportions of type I 
fibres and relative fatness, which is not seen in female mice. This indicates that as 
adiposity increases in male mice there is a decrease in the number of type I fibres (a 
process that is yet to be explained) [121]. However, in this study, the male and female 
mice began the HFD (60% kcal fat, lard) when they were very young (21 days) and 
remained on the diet for approximately one year, and therefore reflects a very long 
exposure to a HFD from an early age, relative to most of the literature [121].  
The data from other studies give mixed results – largely based on the muscle 
performance measures that are used and the ages of the animals that are studied. Male 
middle age mouse models have been examined, but instead of looking at the effects of 
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diet-induced obesity over the lifespan, the diet interventions normally begin at middle age 
(9 months of age) for duration of 5 months. Since these are middle age mice, this model 
can be used to examine muscle wasting, or sarcopenia, in conjunction with the effects of 
diet-induced obesity, which is known as “sarcopenic obesity”. In this model, in vivo 
functional muscle tests, including grip strength and sensorimotor coordination, were 
decreased with a HFD (60% kcal fat, lard) [120]. These authors attributed decreases in 
muscle function to the decrease in muscle cross sectional area of gastrocnemius and 
decrease in satellite cells and myonuclei that are associated with muscle repair. Unlike 
plantaris, a mixed but relatively fast twitch muscle, slow twitch soleus muscle weight 
decreased, indicating age-related sarcopenia. In these middle aged male mice, this 
appeared to be due primarily to a loss of type I fibres. Because of their advanced age, 
both control and HFD mice lost muscle mass, but there was a greater effect of sarcopenia 
in the HFD group. In addition, soleus did not appear to take up any more total lipid on the 
HFD, while fast twitch plantaris did increase lipid accumulation [120]. At first glance, 
this appears to disconnect muscle fat overload from muscle fibre loss, but it may be that 
soleus is already loaded with lipids (lipid content of the soleus is almost 2 times higher 
than the plantaris in lean mice) and HFD could not increase the soleus muscle lipid 
content any further. In addition, these authors only measured total muscle lipid and did 
not delineate the different lipid species in muscle (i.e., inert triglycerides, or lipotoxic 
diglycerides and ceramides) making it difficult to ascertain any link between muscle 
function and specific lipid accumulation. 
However, shorter duration (10 weeks) HFD interventions (60% kcal fat, lard) in 
young male mice elicit muscle fibre type specific adaptations. Contrary to the more long 
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term (5 months) study in which a selective loss of type I fibres was observed [120], there 
was a shift towards oxidative type I fibres accompanied by increases in total muscle lipid 
content, in a muscle-specific manner. These changes were observed in the relatively fast 
twitch gastrocnemius and plantaris muscles but not in slow twitch soleus muscle. 
However, muscle contractile function (as measured by ex vivo whole muscle stimulation) 
remained relatively similar in these fast twitch muscles, with only a decrease in relative 
force post fatigue with a HFD [117].  
These fibre type specific changes have also been reported in HFD interventions 
using a lower amount of fat (45% kcal fat, lard or palm oil), but with added sucrose 
[116]. In this very recent study, even using a short duration diet intervention (5 weeks) in 
young mice (12 weeks old), fibre type specific changes were elicited. As expected, the 
HFS had little effect on soleus muscle lipid content, but there was a significant increase 
in EDL total muscle lipid content. Muscle-specific contractile changes were also 
observed. Only fast twitch EDL had a slower relaxation time, while soleus had a decrease 
in peak twitch force, twitch force time integral, peak tetanic contraction, tetanic force 
time integral and faster relaxation time. However, in the case of this study the source of 
fat, lard or palm oil, played a role in altering muscle contractile force, with more 
detrimental effects elicited by palm oil compared to lard [116].  
Taken together, these results suggest that slow twitch muscles, such as soleus, do 
not further increase their normally high intramuscular total lipids with diet-induced 
obesity, while fast twitch muscles, such as EDL and plantaris, are more adversely 
affected by increased muscle lipid content. However, there is a gap in the literature 
comparing in vivo (e.g. sensorimotor coordination and grip strength) and ex vivo (e.g. 
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stimulated muscle contractions) muscle functions. The effects of diet-induced obesity are 
not just isolated to muscle, but affect the entire body. As previously discussed, bone and 
muscle work in conjunction for body support and movement, and therefore there is a need 
to study the effects of aging and a high fat lifestyle in both tissues simultaneously. 
Skeletal Muscle and Aging 
With aging there is an inevitable decline in muscle strength and muscle mass, which 
is termed as sarcopenia. In addition to this decline, there is a decrease in muscle force 
production per unit of muscle mass meaning there is deterioration in muscle function and 
efficiency [122]. This suggests a greater decline in the function of the muscle than the 
quantity. This phenomenon of a disproportionate loss in muscle strength compared to 
muscle mass has been observed in humans with an approximate a 3-fold greater loss in 
muscle strength compared to muscle mass, in both men and women [4]. Although this 
relationship between muscle and aging is well established, the mechanism contributing to 
alterations in skeletal muscle mass, strength, and function with aging remains less 
understood. 
Effects of Aging on Skeletal Muscle 
Specific age-related changes have been established, which include decreases in 
muscle protein turnover and synthesis, remodeling of motor units, and alteration in fibre 
type [122]. Similar to bone, muscle is remodeled to meet its functional demands, 
however, with aging this become dysregulated and there is less protein synthesis resulting 
in this age-related decline in muscle mass [122], with a specific decline in the synthesis 
of myosin heavy chains, a key protein in muscle contraction [123]. In addition to this 
decline in protein turnover and synthesis, there is a remodeling of motor units, mainly a 
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result of denervation of some muscle fibres with re-innervation by surrounding motor 
nerves, or overall loss of motor units as a whole [16]. This alteration in muscle fibre 
innervation contributes to the co-expression of myosin heavy chains in muscle fibres, 
which determines muscle fibre type [124]. Alterations in muscle fibre type with aging are 
contradictory with some studies suggesting a shift towards type I fibres, others suggesting 
a shift towards type II, and many with inconclusive results [15]. 
This unresolved research question could be in part due to the difficulties in muscle 
fibre typing with aging since many muscle fibres co-express two myosin heavy chains 
simultaneously as previously mentioned. If denervated muscle fibres are not re-
innervated they die, resulting in a greater atrophy of fast fibre types compared to slow 
fibre types since fast fibre types are more likely to become denervated [16]. Therefore 
some fast-twitch dominant muscles atrophy while other do not, making the effects on 
aging muscle fibre type specific [125]. Weight bearing muscles, specifically those with a 
high proportion of type IIb fibres, atrophy more than non-weight bearing muscles [125]. 
These alterations in muscle fibre type and atrophy alter muscle contractile properties of 
any given muscle. 
Both maximum isometric force production and maximum power have been found 
to decline with age [114, 115, 126, 127]. It has previously been reported that soleus and 
EDL muscles of aged mice (26-27 months of age) produce significantly less maximum 
tetanic force than their middle aged counter parts (9-10 months of age) [114]. In addition, 
half relaxation time in soleus but not EDL for aged mice was increased compared to 
young mice (2-3 months of age), but force-velocity relationship between soleus and EDL 
remained unchanged with age [114]. In contrast, there are age-related declines in velocity 
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when concentrically contracting against heavy loads comparing male mice from adult (6-
7 months), old (~24 months), and elderly (~28 months) [115]. In terms of time to reach 
maximum force, there was only an increase in contraction time with elderly mice 
compared to old and adult mice in EDL but not soleus [115]. In another study, comparing 
EDL of young (2-3 months), middle aged (12-13 months), and old (26-27 months) mice 
also found lower absolute power and normalized power to muscle mass, as well as an 
increase in fatigability with a lower tolerance to sustain power with repeated contractions 
[127].  
The loss in muscle force generating capacity with aging can be partly attributed to 
this reduction in muscle mass, and the differential atrophy and innervation of the fibre 
types explains some of the fibre dependent alterations with aging. This progressive 
muscle wasting with aging plays a major role in frailty and functional ability to complete 
tasks of daily living, making it an important area of study [122]. By combining muscle 
contractile function experiments with changes in muscle mass in the present study, both 
the quality and quantity of muscle will be measured for a more comprehensive 
understanding of the changes in muscle with a HFD and aging.   
Bone and Muscle Relationship 
It is clear that bone and muscle are physically inter-dependent. Bone and muscle 
are integrally linked throughout the lifespan, with both tissues undergoing age-related 
declines in structure and function (Figure 2.2) [3, 122]. However, it remains unknown 
how diet induced obesity alters this age-related decline in bone and muscle. There is 
growing evidence of a link between osteoporosis and sarcopenia, with individuals with 
sarcopenia at a greater risk of osteoporosis and vice versa, which is hypothesized to be 
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connected by the mechanostat theory [128]. It is suggested that muscle force has a greater 
influence on bone than body weight alone [129, 130]. However, there are limited studies 
examining how muscle influences bone, even though muscle-generated loads play a key 
role in bone size and structure.  
The majority of research investigating the ratio of outcomes of bone and muscle 
and how these ratios are altered with aging has been in humans (reviewed in [9]). A ratio 
between outcomes of bone (e.g., BMD, bone CSA) and muscle (e.g., muscle force, 
muscle CSA, lean mass) exists since bone and muscle are inter-dependent, however the 
alteration in this ratio with aging is controversial with general findings of no change or an 
increase, suggesting that these two tissues either change in a coordinate manner or muscle 
declines at a greater rate than bone [9]. A lack of continuity between findings may be due 
to different outcomes that are measured, sites measured, and age of humans being 
studied. BMD or bone CSA only captures alterations in bone quantity and not bone 
structure and human models limit the measures that can be used to assess bone and 
muscle, while rodent models allow for more detailed measures. Age related declines in 
bone and muscle in mice follow the same pattern as in humans making it an accelerated 
model for studying the effects of aging [15, 131]. Similar to human studies, using a 
mouse model comparing the ratio bone (mid-diaphysis tibia ultimate load) to muscle 
(EDL peak tetanus normalized to CSA) outcomes using male C57BL/10 mice at 7 and 24 
months of age also found no alteration in this relationship [132]. In addition to the 
limitations using a human model, there have also been advances in technology that allow 
for more accurate measures such as bone structure using µCT.  
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Previous human literature mainly assessed bone health by measuring BMD and 
bone CSA – which provide insight in the quantity of mineral and bone size but no 
information about bone structure. Therefore, the present study measured both BMD and 
bone structure throughout the study duration providing more detailed measures of bone, 
while muscle function testing allowed muscle forces to be measured in addition to muscle 
CSA. This allowed for a comparison between previously calculated ratios (e.g., BMD to 
muscle CSA) to newer ratios (e.g., bone structure to muscle force). Since both 
osteoporosis and sarcopenia have a high prevalence and serious consequences with aging, 
it is important to study the effects of a HFS superimposed with aging to understand 
musculoskeletal health as a unit. Studying the influence of a HFS is especially important, 
since many Canadians exceed the upper limit for fat, which is suggest to 20-35% caloric 
intake for individuals 19 and older [133]. 
 
Figure 2.2. Effects of aging on muscle and bone structure and function. Aspects of how a 
HFS modulate these pathways was studied in this thesis. 
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Chapter 3: Statement of the Problem and Study Objectives 
The effect of a HFS over the lifespan is a relevant area of research with rising 
obesity rates and our aging population. The suggested inverted ‘U’ shaped curve 
associated with a HFS on bone health creates an interesting dichotomy and suggests that 
while the increased adiposity induced by an obesogenic diet in young adult mice (12 
weeks old) can positively affect bone health, there are decreasing bone apposition rates 
and increased fragility and fractures in later life. In addition, the changes in muscle 
contractile properties with diet-induced obesity remain poorly understood. While there 
are a few studies that have investigated the response of young adult animals to diet-
induced obesity, fewer have investigated the combination of a diet-induced obesity and 
aging, which is important since bone and muscle both decline with age and nutrition 
plays an integral role or musculoskeletal health. Furthermore, bone and muscle tissue has 
traditionally been studied separately and not simultaneously. Since bone and muscle are 
integrally linked it is important to study both tissues together to have a comprehensive 
understanding of changes in the musculoskeletal system. The objectives of this study are 
to determine if and how a 13-week obesogenic diet, high in fat and sucrose, fed to 20-
week old (middle aged) C57BL/6J male mice modulates bone and muscle structure and 
function, compared to aging alone. In addition, how aging on aging superimposed with an 
obesogenic diet alters the ratio of bone and muscle outcomes. A 13-week diet 
intervention was selected since it is a long-term diet intervention and similar diet 
durations have previously been used [72, 81, 82, 85]. To better understand the inverted 
‘U’ shape curve model, middle aged (20 weeks old) C57BL/6J mice were used instead of 
using young adult mice (12 weeks old) and extending the HFS (from 11 weeks to 15 
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weeks) due to the logistics and time constraints of extending the diet versus using older 
mice.  
Hypotheses 
1. The aging group will have a steady decline in bone structure and BMD throughout 
the 13-week study, while the group fed obesogenic diet (HFS-AGE) will initially 
be protected from the age-related bone loss due to increased body weight, but 
would have an exacerbated decline in bone structure and BMD at older ages. 
2. The aging group would have a decline in muscle function compared to the 
baseline group, while the HFS superimposed with aging group would have an 
exacerbated decline in muscle function associated with aging as a result of 
disruptions in muscle signaling. Specifically, the soleus force production and EDL 
relaxation time would be negatively impacted by the HFS. 
3. The ratio of bone to muscle will be constant in the aging group, indicating that 
these two tissues decline in a coordinate manner. Although the ratio of bone to 
muscle will also remain constant in the high fat diet superimposed on aging 
group, this would be a result of both the bone and muscle structure and function 
being negatively affected to a similar extent by a high fat diet in aging animals. 
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Chapter 4: Methods 
Animals  
 All procedures that involved animals were in compliance with the Canadian 
Council on Animal Care and approved by the Brock University Animal Care Committee 
(AUP #06-01). Middle aged wild-type male C57BL/6J mice (26.9 ± 1.9 g, 19 weeks old, 
n = 36) were ordered from Jackson Laboratories (Bar Harbor, Maine, USA) and were 
allowed to acclimatize for 5 days in the Comparative Biosciences Facility. All mice were 
kept on a standard 12-hour light: 12-hour dark cycle and had ad libitum access to food 
and water throughout the study. Mice were randomized to baseline (BSL, n = 12), control 
aging (AGE, n = 12), or high fat diet in combination with aging (HFS-AGE, n = 12) 
groups (refer to Figure 2 for experimental design flow chart). Unfortunately, during the 
BSL measures a mouse from the high fat diet group severely injured its cage mate 
resulting in euthanasia. As a result, a weight-matched mouse from the BSL group was 
moved to the high fat diet experimental group and all mice were separated and 
individually housed as a precaution against the male C57BL/6J aggressive tendencies 
towards other males. During acclimatization and BSL measures all mice were fed 
standard chow (2014 Teklad global 14% protein rodent maintenance diet, Harlan 
Tekland, Mississauga, ON). 
Experimental Design 
The in vivo BSL measures conducted at 20 weeks of age for all mice (n= 36) 
included grip strength testing, in vivo scans of the lower right hind limb by µCT, and in 
vivo body µCT scans. Following in vivo measures, the BSL group (n= 11) were 
euthanized at 22 weeks of age, while the control (AGE, n = 12, diet TD.94048, Harlan 
Teklad, Mississauga, ON) and high fat and sucrose diet (HFS-AGE, n = 12, diet 
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TD.150448, Harlan Teklad, Mississauga, ON) groups were switched to their respective 
diets for the 13-week diet intervention (Table 4.1). Throughout the diet intervention the 
control and HFS groups underwent grip strength testing, in vivo body scans, and in vivo 
leg scans, at 20, 24, 28, and 32-weeks of age to measure longitudinal changes due to 
aging and the obesogenic diet. In addition, body weight and food intake were measured 
three times a week throughout the study. The AGE and HFS-AGE groups were 
euthanized when the mice were middle aged at 33-weeks of age for further measures. 
 
Figure 4.1. Flow chart of study design. Leg scans and body scans completed using a µCT 
(Bruker SkyScan 1176, Kontich, Belgium). Grip strength testing included all four limbs 
and the front limbs only using a grid and T-bar, respectively, attached to a grip strength 
meter (Bioseb, Pinellas Park, FL). Calcein green and alizarin red injected for bone 
histology to measure mineral apposition rate. CRN is an abbreviation for the Cairns 
Family Health and Biosciences building. 
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Experimental Diets 
Harlan Teklad Diet assisted in creating diets that were consistent with previous 
high fat studies [72, 81, 82, 116] and were matched as closely as possible for protein, 
minerals, and vitamins on an energy basis. To be able to study the effects of dietary fat 
content on the rate of decline of bone with aging, it was important to keep levels of key 
micronutrients, especially calcium, phosphate, and vitamin D, consistent per energy so 
that only the effect of the high fat and sucrose levels were being studied. By design, the 
HFS contains a higher level of energy by weight. Thus, if micronutrients are not adjusted 
per unit of energy, the level of micronutrients per kcal is lower in mice fed the HFS 
compared to control diet. The majority of studies in the literature do not do this 
adjustment so it is uncertain whether reported adverse effects on bone health are due to 
the higher level of fat and sucrose in the diet or the lower level of micronutrients known 
to be critical for supporting bone health or possibly both. The level (45% kcal) and source 
(lard) of fat used in this study is similar to that commonly used in other studies that have 
examined the effects of a diet-induced obesity on either bone [72, 81, 82] or muscle [116] 
individually. Since vitamin D is fat-soluble and positively affects bone, it was important 
to match the diets for vitamin D content. Since lard is known to contain vitamin D, the 
lard used in the modified AIN-93M HFS was tested for vitamin D content, but none was 
detected by a third party lab (Covance). As a result, the standard AIN-93M vitamin mix 
was used for both the control and HFS diets. Although, there is no specific requirement 
level for alpha-linolenic acid in mice, soybean oil was included in the diets so that mice 
received a sufficient amount of alpha-linoleic acid and linoleic acid. Specific composition 
and ingredients of the control and HFS are listed in Table 4.1. 
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Table 4.1. Study diet composition and ingredients. 
 Control Diet (AIN-93M) Modified AIN93M Diet  
Protein (% kcal) 13.7 13.8 
Carbohydrate (% kcal) 75.9 40.8 
Fat (% kcal) 10.3 45.3 
Energy (Kcal/g) 3.6 4.6 
 
Ingredient 
 
g/kg 
 
g/kg 
Casein 140.0 180.0 
L-Cystine 1.8 2.3 
Corn Starch 465.7 154.2 
Maltodextrin 155.0 115.0 
Sucrose 100.0 200.0 
Lard -- 200.0 
Soybean Oil 40.0 30.0 
Cellulose 50.0 58.0 
Mineral Mix, AIN-93M-
MX (94049) 
35.0 44.8 
Vitamin Mix, AIN-93M-
VX (94047) 
10.0 12.8 
Choline Bitrate 2.5 3.0 
TBHQ, antioxidant 0.008 0.008 
 
Body Weight and Food Intake 
 Body weight was recorded three times a week on the same day for all animals 
using a pan balance. Food intake was measured three times a week (food provided-food 
remaining) and was replaced with fresh food three times a week. From these food intake 
measurements, the total amount of food consumed per day was calculated (g/day), from 
which food intake per day was normalized to body weight (food g/day/body weight g) for 
each mouse. In addition to food intake, energy intake (kcal/day) was also calculated by 
multiplying the food intake per day by the energy density (kcal/g) of the diets (AGE diet 
3.6 kcal/g and HFS-AGE 4.6 kcal/g), from which energy intake was normalized to body 
weight (kcal/day/body weight g) for each mouse. 
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Surgical Procedures 
Endpoint surgeries for the removal of tissues were conducted under isoflurane 
anesthetic once a surgical plane had been established (i.e., lack of pedal withdrawal reflex 
with a toe pinch). The left leg soleus and EDL muscles were removed tendon to tendon 
with silk sutures 4-0 suture (Surgical Specialties Corporation, Reading, PA) tied at the 
tendons for muscle contractile testing [114, 116], while the right leg muscles were freeze-
clamped immediately for future analysis. The abdominal cavity was opened to sever the 
aorta and vena cava to remove the heart for euthanasia via exsanguination (SOP-
EUTH04, Methods of euthanasia for various animals).  
In Vivo Scans Using Micro Computed Tomography 
In vivo body scans (body composition: fat, lean, and bone mass) and hindlimb 
scans (bone structure) were completed using the Bruker SkyScan 1176 µCT (Kontich, 
Belgium). Mice were anaesthetized in an induction chamber with isoflurane at a constant 
flow rate of 3-5% and transitioned to a nose cone for maintenance of the anesthetic (SOP-
HEAL25), Use of isoflurane in rodent surgeries using a vaporizer). For body scans of the 
abdominal region mice were laid supine and the entire lumbar vertebra was included in 
the scanning field using the thoracic vertebra as landmarks, identified by the ribs, and the 
top of the sacrum. Body scans were conducted with a standard resolution using a 1 mm 
aluminum filter at 40 kilovolts and 200 microamps, with a 430 millisecond exposure time 
and a rotation step of 0.8°. For leg scans the mice were positioned in right lateral 
recumbency with the right hind leg extended and secured to the scan bed with styrofoam 
and dental wax. The entire tibia was included in the scanning field using the ankle and 
knee joint as landmarks. Leg scans were conducted with a high resolution using a 1 mm 
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aluminum filter at 40 kilovolts and 200 microamps, with a 430 millisecond exposure time 
and a rotation step of 0.7°. These in vivo measures were repeated on the control and HFS 
groups throughout the study at 20, 24, 28, and 32 weeks of age to measure longitudinal 
progression of aging and aging plus a HFS on body composition, bone structure, and 
BMD.  
After completion of all the in vivo scans images were processed and analyzed 
using the same parameters for all samples for either the leg scans or body scans. 
Reconstruction parameters (Table 4.2) were set in NRecon (software version 1.6.9.10, 
Bruker, Kontich, Belgium) and image reorientation was performed using Dataviewer 
software (software version 1.5.1.3, Bruker, Kontich, Belgium) to orientate samples as 
vertical as possible. Following which, regions of interest were selected and analyzed 
using CTan software (software version 1.14.4.1+, Bruker, Kontich, Belgium). The tibia 
region of interest was set using the end of the growth with an offset of 30 slices and 
region of interest of 60 slices, while the body scan region of interest was landmarked by 
the beginning and end of the third lumbar vertebra. The tibia was analyzed by setting up a 
task list to automatically separate trabecular from cortical bone using a task list (Table 
4.3), while body scans were analyzed by setting ranges for fat (1-35), fat free (36-84), and 
bone tissues (85-255). During the study phantoms were scanned once per scan period (i.e. 
20, 24 weeks) to calibrate the µCT for BMD.  
Table 4.2. Reconstruction parameters for in vivo scans of proximal tibia and body 
composition. 
 In vivo leg scans In vivo body scans 
Beam hardening 40% 30% 
Ring artifact 8 8 
Smoothing 4 8 
Dynamic threshold 0.0 – 0.110 0.0 – 0.056 
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Table 4.3. Task list for in vivo analysis of proximal tibia  
  
Thresholding low 90, high 255 
Despeckle sweep, all except largest, image, 3D space 
ROI shrink wrap shrink wrap, 2D space 
Bitwise operations image = NOT image 
Bitwise operations image = image & ROI 
Morphological operations opening, round image, 2D space, radius=2 
Despeckle sweep, all except largest, image, 3D space 
Morphological operations closing, round, image, 2D space, radius=10 
Morphological operations opening, round image, 2D space, radius=10 
Morphological operations erosion, round image, 2D space, radius=3 
Morphological operations dilation, round image, 2D space, radius=2 
Bitwise operations ROI = ROI sub image 
Reload image 
Save bitmaps image inside ROI, BMP, copy dataset to 
log files 
Save bitmaps ROI, BMP, convert to monochrome 
Thresholding low 90, high 255, copy dataset to log file 
ROI shrink wrap shrink wrap, 2D space 
Structure  2-D analysis 
BMD histogram 
 
Grip Strength Testing  
Grip strength testing was used as a functional in vivo measure of muscle strength 
using a Bioseb Grip Test 3 system. The grip strength of all four limbs and front limbs 
only was measured by either using a grid for all four paws or a T-bar for the front paws 
only. Once mice had a grip they were gently pulled backwards horizontally until the grip 
was released. The grid and T-bars were attached to a grip strength meter (Bioseb, Pinellas 
Park, FL) that measured the force produced. Each grip strength test for all four limbs and 
front limbs was performed in triplicate. Outliers were excluded if they were two standard 
deviations above or below the average and results were reported as the group average of 
the averaged three grip strength tests for each mouse.  
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Muscle Contractile Function Tests 
Muscle contractile experiments were conducted on In Vitro Muscle Testing Systems 
from Aurora Scientific Inc. (Aurora, Ontario) using the soleus and EDL muscles excised 
during the surgical procedures. The soleus was chosen as a representative slow twitch 
muscle (approximately 30% type I fibres and 49% type IIa fibres) and EDL was chosen 
as a representative fast twitch muscle (approximately 24% type IIx and 56% type IIb 
fibres) [110]. These systems allow for the control of muscle length, shortening and 
lengthening speed, and temperature. The excised muscles were suspended by the sutures 
tied at the proximal and distal tendons of the muscle in a vertical organ bath containing 
Tyrodes solution (Table 4.4) continually being circulated with 95% O2 and 5% CO2, 
maintained at a temperature of 25°C. Tyrodes solution is an isotonic physiological saline 
solution that simulates the in vivo environment, providing the muscle with all the 
essential substrates and ions to survive during the contractile experiments and 
maintaining normal osmolarity. The viability of a muscle following excision is of great 
importance, by using fusiform muscles such as mouse soleus and EDL the muscle 
diameter is small enough to receive sufficient oxygenation and substrate delivery through 
diffusion at 25oC, even to support muscle contraction [134]. 
Once muscles were set up in the vertical organ baths, muscle resting length was 
arbitrarily set to 12 mm with a resting tension between 3-5 mN, followed by a slip tetanus 
protocol (100Hz for 400ms) to prevent slippage of the sutures at the tendon-suture 
junction. Muscles were then allowed to equilibrate, with individual muscle twitches (1 Hz 
for 100 ms) stimulated at 3-minute intervals for either the 30-minute equilibration 
protocol or until the twitch force had stabilized (i.e., no change in the magnitude of the 
twitch force). Following equilibration, the muscle length at which the maximal active 
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twitch force (Pt) was produced, known as the optimal length (Lo), was calculated. This 
was accomplished by stimulating the muscle to produce single twitches (1 Hz for 100ms) 
at various lengths. Force traces were analyzed to determine the Pt, calculated by 
subtracting passive force (i.e., resting tension) from total force, and using that resting 
tension to determine optimal length for the muscle being tested. Muscle length was 
measured using digital vernier calipers (Electron Microscopy Sciences, Hatfield, PA) 
with the adjusted resting tension at which Pt was measured. This muscle length was then 
set as the new Lo in the software, which was used as the reference length for the 
experimental protocol. Following these standard procedures, the muscles were ready for 
the experimental protocol.  
Two slightly different systems were used for the soleus and EDL, due to the 
duration of the contractile protocols all soleus were analyzed on one system and all EDL 
analyzed on the other. This was not an issue because soleus and EDL were not being 
compared. For soleus parallel platinum electrodes controlled by a 701C biphase 
stimulator stimulated soleus to contract. Data was collected using a 305C servomotor 
acquired through a 604A analog-to-digital interface controlled by a 305C dual-mode level 
system. The ASI600a software (version 3.210) was used for data acquisition and basic 
analysis. For EDL, parallel platinum electrodes controlled by a 701B biphase stimulator 
stimulated the EDL to contract. Data was collected using a 300C-LR servomotor acquired 
through a 604A analog-to-digital interface controlled by a 300C-LR dual-mode level 
system. The ASI600a software (version 1.60) was used for data acquisition and basic 
analysis and data was exported to Excel for both the soleus and EDL for further analysis 
(Microsoft Canada Co., Mississauga, ON). 
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Aside from slight differences in the systems, the experimental protocol only 
varied by the maximum stimulation, because soleus is a slow twitch muscle it requires a 
lower stimulation frequency compared with EDL, since it is a fast twitch muscle and 
requires a high stimulation frequency. Soleus was stimulated at 120 Hz and EDL was 
stimulated at 150 Hz. Muscle contractile measures for both soleus and EDL included 
isometric twitch peak force, isometric tetanus peak force, force-frequency curve, 
maximum shortening speed, half relaxation time, rate of force development (+df/dt), and 
rate of relaxation (-df/dt). 
Table 4.4. Composition of Tyrodes solution. 
Compound Grams/L 
Sodium Chloride 7.07 
Potassium Chloride 0.37 
Sodium Bicarbonate 2.02 
D-Glucose 0.99 
Sodium Hydrogen Phosphate 0.05 
Magnesium Chloride 0.05 
EDTA 0.03 
Calcium Chloride 0.20 
 
Muscle CSA 
Muscle CSA was calculated for both soleus and EDL using the following calculation, 
CSA = (m / l*d*(Lf/Lo)) 
Where m is for muscle mass (mg), l is for muscle length (mm), d is for mammalian 
skeletal muscle density (1.06 mg/mm3) [135], and Lf/Lo is the fibre length-to-muscle 
length ratio (soleus 0.71 and EDL 0.44) [114].  
Muscle Function Analysis 
 Muscle viability was determined based on tetanus peak force cut offs for the 
soleus (<150 mN) and EDL (<200 mN), if muscles produced less than the cut off they 
were not considered viable. Resting tension was subtracted from peak twitch or tetanus 
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peak force to calculate peak force and normalized to muscle CSA (mN/mm2). Rate of 
force production and rate of force relaxation data was smoothed using a moving average 
of 17 time points to account for oscillations in the force traces and the maximum was 
determined from this smoothed data. Both peak twitch and tetanus half relaxation time 
were calculated by subtracting the time of half the peak force (peak force/2) from the 
time of peak force. As for the slack test, the ASI600a software was used to view tetanus 
traces, the time for force redevelopment was recorded at 3 mN for the soleus and 10 mN 
for the EDL. The recorded time points for each change in L0 (10%, 12.5%, 15%, 17.5%, 
20%) were plotted to calculate the y-intercept (slope= %L0/ms), which was converted to 
muscle lengths per second (y-intercept/100) and divided by the fibre length factor (soleus 
0.71, EDL 0.44) [114]. The force frequency curve was plotted by subtracting the resting 
tension from the peak force for each frequency then normalized to the peak force 
produced for the force frequency curve (% maximum force). 
Ratio of Outcomes of Bone and Muscle  
Bone and muscle outcomes were chosen to represent the structure and/or function of 
these tissues. To represent trabecular structure proximal tibia BV/TV was selected since it 
is a responsive to alterations in diet, while vBMD was selected as a measure of bone 
quantity and has previously been used as an outcome to calculate bone to muscle ratios 
[9]. As for muscle, peak tetanus force was selected as the representative functional 
measure, while CSA was selected as a measure muscle quantity. Ratios included 
BMD:CSA, BMD:peak tetanus, BV/TV:CSA, and BV/TV:peak tetanus. 
 
 
	   	   43	  
Muscle Immunohistochemistry 
Upon completion of the contractile experiments both soleus and EDL were set in 
an embedding compound (Cryomatrix, Pittsburgh, PA) for muscle fibre typing with 
specific myosin heavy chain (MHC) antibodies. Muscles were orientated longitudinally 
in Cryomatrix, frozen in 2-methylbutane and stored at -80°C until further analysis.  
Soleus and EDL were sliced at -20°C into 10 µm sections using a cryotome 
(77200187 Issue 5; ThermoShandon, Runcorn, UK) and placed on a microscope slide 
that had been vectabonded (Vectabond Reagent for Tissue Section Adhesion, SP-1800; 
Vector Laboratories, Burlingame, CA). Slides were then stained for myofibrillar ATPase 
to determine muscle fibre type. Staining began by blocking muscle sections with 10% 
goat serum (G9023; Sigma-Aldrich, St. Louis, MO) in 1x phosphate buffer saline (1 
tablet dissolved in 200 mL distilled water; P4417; Sigma-Aldrich, St. Louis, MO) (100 
µL/slide) for 1 hour at room temperature, followed by a primary antibody concoction of 
MHCI (1:50 dilution; BA-F8-s; Developmental Studies Hybridoma Bank, University of 
Iowa, Iowa City, IA), MHCIIa (1:600 dilution; SC-71-s; Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA), and MHCIIb (1:100 dilution, BF-
F3-s; Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) 
appropriately diluted in 10% goat serum blocking solution (100 µL/slide) for 3 hours at 
room temperature. Slides were then washed in 1x phosphate buffer saline three times for 
5 minutes and the secondary antibody concoction, Alexa Fluor 350 anti-mouse IgG2b 
(1:500 dilution, A-21140; Life Technologies, Eugene, OR), Alexa Fluor 488 anti-
mouse IgG1 (1:500 dilution, A-21121; Life Technologies, Eugene, OR), and Alexa Fluor 
555 anti-mouse IgM (1:500 dilution, A-21426; Life Technologies, Eugene, OR), was 
appropriately diluted in 10% goat serum blocking solution (100 µL/slide) for 1 hour at 
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room temperature in the dark. Again slides were washed in 1x phosphate buffer saline 
three times for 5 minutes prior to applying ProLong Gold antifade reagent (P10144; 
Molecular Probes, Eugene, OR) and a #1 coverslip (12-542B; Fischer Scientific, 
Waltham, MA) [110]. 
Muscle sections were viewed at 20x magnification using a Zeiss Axio Observer 
Research Microscope (491912-0003-000; Zeiss, Oberkochen, Germany) attached to a 
digital camera (ORCA-Flash4.0 V2 Digital CMOS camera; C11440-22CU; Hamamatsu 
Photonics K.K., Japan) and ZenPro software (Zen 2 blue edition; version 2.0.0.0; Zeiss, 
Oberkochen, Germany) to tile and stitch images together. ImageJ software was used to 
calculate the number and area of each fibre type, which was determined manually 
depending on the fibre stain.  
Statistical Analysis 
 Body weight and food intake were analyzed with a repeated measures one-way 
ANOVA. Grip strength (front limbs and four limbs), body composition (percent lean 
mass, percent fat mass, and percent bone mass), tibia structure (BV/TV, Tb.Th, Tb.N, 
Tb.Sp, and BMD), were analyzed with a repeated measures two-way ANOVA with group 
and age as factors. Muscle function tests for soleus and EDL (CSA, peak twitch, peak 
tetanus, rate of force development, rate of relaxation, half relaxation time, maximum 
unloaded shortening velocity, and force frequency) were analyzed with a one-way 
ANOVA. Statistical significance was accepted at p < 0.05. 	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Chapter 5: Results 
Body Weight & Food Intake 
At 20 weeks of age, when mice were randomly assigned to the BSL, AGE, or 
HFS-AGE groups, there were no differences in body weight among groups. Following 
the 13-week intervention, the HFS-AGE group weighed 30% more than the AGE group 
(p<0.0001) (Figure 5.1). There was an interaction for energy intake (kcal/day), with the 
HFS-AGE group having a higher energy intake compared to the AGE group (p<0.0001) 
(Figure 5.2.A.). However, when energy intake was normalized to body weight (kcal/body 
weight/day) there was an overall interaction (p<0.0001) but no main effect for group 
(Figure 5.2.B). 
 
Figure 5.1. Body weights of AGE (n=12) compared to HFS-AGE (n=11) mice from 20 
weeks of age to 33 weeks of age. Data are reported as mean±SE. *, signifies significant 
differences between AGE and HFS-AGE groups at a specific time point. There was an 
overall interaction (p<0.0001) with a main effect by group (p<0.0001) and over time for 
the HFS-AGE group (p<0.0001) but not the AGE group. 
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Figure 5.2. Energy intake (kcal/day) and energy intake normalized to body weight 
(kcal/body weight/day) for AGE (n=12) compared to HFS-AGE (n=11) groups from 20 
weeks of age to 33 weeks of age. Data are reported as mean±SE *, signifies significant 
differences between AGE and HFS-AGE groups at a specific time point. (A) There was 
an interaction for energy intake with the HFS-AGE group having a higher energy intake 
than the AGE group (p<0.0001). (B) There was an overall interaction for energy intake 
normalized to body weight (p<0.0001), but no main effect for group. 
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Body Composition 
From 20 weeks to 33 weeks of age both AGE and HFS-AGE had declines in lean 
mass (p<0.0001), however HFS-AGE had a greater decrease (46%) compared to AGE 
(13%) (p<0.0001) (Figure 5.3.A). Fat mass increased in both AGE and HFS-AGE 
(p<0.0001), with HFS-AGE group having a greater increase (79%) compared to AGE 
(51%) (p<0.0001) (Figure 5.3.B). There was an overall interaction for bone mass, with 
differences between groups at 28 weeks (p<0.0001) and 33 weeks (p<0.0001) as a result 
of an increase in AGE and decrease in HFS-AGE (Figure 5.3.C).  
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Figure 5.3. % lean mass, fat mass, and bone mass were measured at the mid-truncal 
region for AGE (n=12) and HFS-AGE (n=11), with the third lumbar vertebra as a 
landmark for exact positioning using µCT. Data are reported as mean±SE *, signifies 
significant differences between AGE and HFS-AGE groups for each time point, while 
letters signify significant differences between time points within a group (a, compared to 
20 weeks; b, compared to 24 weeks; c, compared to 28 weeks). (A) Relative lean mass 
had an interaction (p<0.0001) with a 13% decline in the AGE group compared to the 46% 
decline in the HFS-AGE group and an overall decrease in lean mass over time for both 
groups. (B) Relative fat mass had an interaction (p<0.0001). The AGE group had a 51% 
increase in fat mass compared to the 79% increase in fat mass for the HFS-AGE group 
and an overall increase in lean mass over time for both groups. (C) % bone mass had an 
interaction (p<0.0001) with differences between groups at 28 weeks (p<0.0001) and 33 
weeks (p<0.0001). There was an increase in % bone mass over time for the AGE group, 
while there was a decline over time for the HFS-AGE group. 
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Structure and BMD of Proximal Tibia 
 Proximal tibia structure was compromised with aging, and feeding a HFD did not 
alter this relationship. BV/TV declined from 20-week of age (BSL) to 24-weeks of age, 
followed by a maintenance period to the study end point at 33-weeks of age. Over the 13-
week intervention, the decrease in BV/TV was similar for AGE (34% decrease) and HFS-
AGE (45% decrease) (p<0.0001) (Figure 5.4.A). Tb.Th similarly declined in both groups 
(9% for AGE, 8% for HFS-AGE) over the 13-week intervention (p<0.05) (Figure 5.4.B). 
Tb.N also declined over this time period (29% for AGE, 41% for HFS-AGE) (p<0.05), 
however unlike BV/TV and Tb.Th, HFS-AGE did not have a maintenance period from 
24-weeks to 33-weeks of age but declined (p<0.05) (Figure 5.4.C). Tb.Sp increased in 
both AGE and HFS-AGE from 20-weeks to 24-weeks of age (p<0.05), however AGE 
had a decrease in Tb.Sp from 24-weeks to 33-weeks (p<0.05), resulting in an overall non-
significant alteration in Tb.Sp from 20-weeks to 33-weeks of age. In contrast, HFS-AGE 
had no changes in Tb.Sp from 24-weeks to 33-weeks age, resulting in a total overall 
increase of 19% (p<0.05) (Figure 5.4.D). While BMD of proximal tibia had an overall 
interaction (p<0.05) and main effect for time (p<0.001), there was no main effect 
between AGE and HFS-AGE. BMD continually declined from 20-weeks to 33-weeks of 
age with a similar total overall decrease in both AGE (17% decrease) and HFS-AGE 
(23% decrease) with no differences between groups (Figure 5.5). Overall, aging 
negatively impacted bone structure as a result of a decrease in Tb.N and an increase in 
Tb.Sp that contributed to the decline in BV/TV as well as a decline in BMD. Feeding a 
HFS did not alter the effect of AGE alone, as there were no differences between the AGE 
and HFS-AGE groups for any of the proximal tibia measures. 
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Figure 5.4. Proximal tibia bone structure was measured using µCT for the AGE (n=12) 
and HFS-AGE (n=11) groups. Data are reported as mean±SE, letters signify significant 
differences between time points within a group (a, compared to 20 weeks; b, compared to 
24 weeks). (A) BV/TV had no interaction or main effect between AGE and HFS-AGE 
groups, but there was a main effect for time (p<0.0001). (B) Tb.Th had no interaction or 
main effect between AGE and HFS-AGE groups, but there was a main effect for time 
(p<0.0001). (C) Tb.N had an interaction (p<0.05) with no main effect for group, but a 
main effect for time (p<0.0001). (D) Tb.Sp had an interaction (p<0.05) with no main 
effect for group, but a main effect for time (p<0.0001). 
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Figure 5.5. Proximal tibia vBMD was measured using µCT for the AGE (n=12) and 
HFS-AGE (n=11) groups. Data are reported as mean±SE, letters signify significant 
differences between time points within a group (a, compared to 20 weeks; b, compared to 
24 weeks). vBMD had an interaction (p<0.05) ) with no main effect for group, but a 
decrease in BMD over time (p<0.0001). 
 
Grip Strength of Four Limbs and Front Limbs 
 Four limb and front limb grip strength testing (Figure 5.6) showed no interaction 
or main effect between AGE and HFS-AGE. There was a main effect for time for the 
front limb grip strength in both AGE and HFS-AGE, with an overall decline in grip 
strength from 20 weeks to 33 weeks (p<0.05). There was also a main effect for time for 
front limb grip strength with only an increase in front limb grip strength from 20 weeks to 
28 weeks in AGE (p<0.05). 
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Figure 5.6. Mouse grip strength was measured in triplicate for all four limbs and front 
limbs for the AGE (n=12) and HFS-AGE (n=12) groups. Data are reported as the group 
mean±SE of the mean of the triplicate grip strength measure for each mouse, letters 
signify significant differences between time points within a group (a, compared to 20 
weeks; b, compared to 24 weeks; c, compared to 28 weeks). (A) Four limb grip strength 
testing had no interaction or main effect for group, but a main effect for time (p<0.01). 
(B) Front limb grip strength testing had no interaction or main effect for group, but a 
main effect for time (p<0.05). 
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Muscle Contractile Function 
Soleus 
 The soleus CSA of HFS-AGE was 22% greater than AGE (p=0.0008) with no 
difference among any of the other groups (Figure 5.7). However, these alterations in 
muscle CSA did not equate to alterations in muscle function, as there were no differences 
among groups for peak twitch force (Figure 5.8.A) or peak tetanus force (Figure 5.8.B). 
There were no differences in twitch or tetanus rate of force development among groups 
(Figure 5.9). As for rate of relaxation, there were differences in tetanus rate of relaxation 
between BSL and AGE (p<0.001) and BSL and HFS-AGE (p<0.01) (Figure 5.10). In 
contrast to rate of relaxation, the twitch half relaxation time had differences between BSL 
and AGE (p<0.001) and BSL and HFS-AGE (p=0.02), but there were no differences in 
tetanus half relaxation time (Figure 5.11). There was no effect of aging or aging 
superimposed with a HFS on maximum unloaded shortening velocity (Figure 5.12). 
Similarly, there was no shift in the force frequency curve with age or diet (Figure 5.13). 
 
 
Figure. 5.7. Soleus CSA was measured for the BSL (n= 11), AGE (n=11), and HFS-AGE 
(n=11) groups. Data are reported as mean±SE *, signifies significant differences among 
groups. The HFS-AGE group had a greater CSA than the AGE group (p=0.0008) with no 
difference among the other groups. 
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Figure. 5.8. Soleus twitch and tetanus force normalized to CSA was measured for the 
BSL (n= 10), AGE (n=10), and HFS-AGE (n=9) groups. Data are reported as mean±SE. 
(A) There were no differences among groups for peak twitch. (B) There were no 
differences among groups for peak tetanus. 
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Figure. 5.9. Soleus rate of force development was measured for the BSL (n= 10), AGE 
(n=10), and HFS-AGE (n=9) groups. Data are reported as mean±SE. (A) There were no 
differences among groups for twitch force development. (B) There were no differences 
among groups for tetanus force development. 
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Figure 5.10. Soleus rate of muscle relaxation was measured for the BSL (n= 10), AGE 
(n=10), and HFS-AGE (n=9) groups. Data are reported as mean±SE *, signifies 
significant differences among groups. (A) There were no differences among groups for 
twitch rate of relaxation. (B) Rate of relaxation decreased compared to the BSL group for 
both AGE (p<0.001) and HFS-AGE (p<0.01), but there was no difference between the 
AGE and HFS-AGE groups.  
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Figure. 5.11. Soleus half relaxation time was measured for the BSL (n= 10), AGE 
(n=10), and HFS-AGE (n=9) groups. Data are reported as mean±SE *, signifies 
significant differences among groups. (A) There were differences between BSL and AGE 
(p<0.001) and BSL and HFS-AGE (p=0.02), but no difference between AGE and HFS-
AGE. (B) There were no differences among groups for tetanus half relaxation time. 
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Figure. 5.12. Soleus maximum unloaded shortening velocity was measured for the BSL 
(n= 10), AGE (n=10), and HFS-AGE (n=9) groups. There were no differences among 
groups.  
 
 
Figure. 5.13. Soleus force frequency was measured for the BSL (n= 10), AGE (n=10), 
and HFS-AGE (n=9) groups. There was no interaction or main effect for group.  
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EDL 
EDL CSA of AGE had a 13% decrease compared to BSL, whereas there were no 
differences between AGE and HFS-AGE or BSL and HFS-AGE (Figure 5.14). Peak 
twitch normalized to CSA increased from BSL for AGE (p<0.0001) and HFS-AGE 
(p<0.0001), 43% and 53%, respectively, however there was no difference in peak tetanus 
normalized to CSA among groups (Figure 5.15). Twitch rate of force production 
increased by 44% for AGE (p=0.0004) and 53% for HFS-AGE (p<0.0001) compared to 
BSL, however there were no differences among groups for tetanic rate of force 
production (Figure 5.16). Similarly, twitch rate of relaxation increased by 54% for AGE 
(p=0.002) and 49% for HFS-AGE (p=0.004) compared to BSL, whereas tetanic rate of 
relaxation between groups decreased by 74% for AGE (p=0.008) and 74% for HFS-AGE 
(p=0.01) compared to BSL (Figure 5.17). Alterations in rate of relaxation with AGE and 
HFS-AGE did not carry over to half relaxation time (Figure 5.18) or maximum unloaded 
shortening velocity (Figure 5.19) for either twitch or tetanus among groups. However, for 
the force frequency curve there was an interaction (p<0.0001) and main effect for group 
(p=0.0002). Both AGE and HFS-AGE produced greater force than BSL at 20, 30, 40, 50, 
60, 70, and 80 Hz (Figure 5.20). 
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Figure. 5.14. EDL CSA was measured for the BSL (n= 11), AGE (n=11), and HFS-AGE 
(n=11) groups. Data are reported as mean±SE *, signifies significant differences between 
groups. The AGE group EDL CSA was lower than the BSL group (p<0.05), and no 
differences between AGE and HFS-AGE or BSL and HFS-AGE groups.  
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Figure 5.15. EDL peak twitch and tetanus normalized to CSA was measured for the BSL 
(n= 7), AGE (n=9), and HFS-AGE (n=9) groups. Data are reported as mean±SE *, 
signifies significant differences between groups. (A) There were differences for peak 
twitch force between BSL and AGE (p<0.0001) and BSL and HFS-AGE (p<0.0001). (B) 
There were no differences among groups for peak tetanus.  
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Figure 5.16. EDL rate of force production was measured for the BSL (n= 7), AGE (n=9), 
and HFS-AGE (n=9) groups. Data are reported as mean±SE *, signifies significant 
differences between groups. (A) The AGE compared to BSL had a greater rate of force 
production (p=0.0004) and HFS-AGE compared to BSL had a greater rate of force 
production (p<0.0001). (B) There were no differences among any groups for tetanus rate 
of force production. 
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Figure 5.17. EDL rate of relaxation was measured for the BSL (n= 7), AGE (n=9), and 
HFS-AGE (n=9) groups. Data are reported as mean±SE *, signifies significant 
differences between groups. (A) There were differences for twitch rate of relaxation 
between BSL and AGE (p=0.002) and BSL and HFS-AGE (p=0.004). (B) There were 
differences for tetanus rate of relaxation between BSL and AGE (p=0.008) and BSL and 
HFS-AGE (p=0.01). 
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Figure 5.18. EDL half relaxation time was measured for the BSL (n= 7), AGE (n=9), and 
HFS-AGE (n=9) groups. Data are reported as mean±SE. (A) There were no differences 
among groups for twitch half relaxation time. (B) There were no differences among 
groups for tetanus half relaxation time. 
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Figure 5.19. EDL maximum unloaded shortening velocity was measured for the BSL (n= 
10), AGE (n=9), and HFS-AGE (n=9) groups. There were no differences among groups. 
 
 
 
Figure 5.20. EDL force frequency was measured for the BSL (n= 7), AGE (n=9), and 
HFS-AGE (n=9) groups. Data are reported as mean±SE, a, represents significant 
differences between BSL and AGE, and b, represents significant differences between 
BSL and HFS-AGE. There was an interaction (p<0.0001) and main effect for group 
(p=0.0002). 
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Muscle Fiber Typing 
Soleus 
 Soleus type I fibres for HFS-AGE group were 32% larger compared to AGE 
(p<0.0001) and 14% larger compared to BSL (p=0.0002), while AGE had a 20% 
decrease compared to the BSL group (p<0.0001) (Figure 5.21.A). This trend continued 
for soleus type IIa fibres with HFS-AGE group being 30% larger compared to AGE 
(p<0.0001) and 16% larger compared to BSL (p=0.001), while AGE had a 17% decrease 
compared to the BSL (p=0.004) (Figure 5.21.B). As for soleus type IIa-b hybrid fibres, 
HFS-AGE had a 25% larger CSA compared to AGE (p<0.0001) and an 18% larger CSA 
compared to BSL (p<0.0001) (Figure 5.21.C). Similarly, soleus type IIb fibres for HFS-
AGE had a 51% larger CSA compared to AGE (p<0.0001) and a 37% larger compared to 
BSL (p<0.0001) (Figure 5.21.D). However, there was no alteration in the relative 
composition of the soleus muscle (Figure 5.22).  
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Figure 5.21. Soleus muscle fibre type CSA was measured for BSL (n=6), AGE (n=6), 
and HFS-AGE (n=6). Data are reported as mean±SE *, signifies significant differences 
among groups. (A) The type I fibres of the AGE group decreased from BSL (p<0.0001), 
while the HFS-AGE group had an increase in CSA compared to BSL (p=0.0002), with a 
difference between the AGE and HFS-AGE groups (p<0.0001). (B) The type IIa fibres of 
the AGE group decreased from BSL (p=0.004), while the HFS-AGE group had an 
increase in CSA compared to BSL (p=0.001), with a difference between the AGE and 
HFS-AGE groups (p<0.0001). (C) The hybrid type IIa-IIb fibres of the HFS-AGE group 
had an increase in CSA compared to the BSL group (p<0.0001) and the AGE group 
(p<0.0001). (D) The type IIb fibres of the HFS-AGE group had an increase in CSA 
compared to the BSL group (p<0.0001) and the AGE group (p<0.0001). 
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Figure 5.22. Soleus muscle fibre type composition was measured for the BSL (n=6), 
AGE (n=6), and HFS-AGE (n=6). There were no alterations in fibre the soleus fibre type 
composition.  
 
EDL 
EDL type IIa fibres for HFS-AGE were 23% smaller compared to AGE (p<0.0001) 
and 14% smaller compared to BSL group (p=0.006) (Figure 5.23.A). For EDL type IIa-
IIx hybrid fibres, AGE had 24% larger fibres compared to BSL group (p=0.01) (Figure 
5.23.B), whereas type IIx fibres in both AGE (p=0.0005) and HFS-AGE (p=0.004) were 
larger compared to BSL (18% and 16%, respectively) (Figure 5.23.C). The CSA of type 
IIx-IIb hybrid fibres were smaller for HFS-AGE compared to AGE (19% decrease, 
p=0.02) and BSL (28% decrease, p<0.0001) (Figure 5.23.D). The type IIb fibres followed 
the same trend with HFS-AGE having smaller fibres compared to AGE (11%, p=0.04) 
and BSL (14%, p=0.004) (Figure 5.23.E). For EDL fibre composition there was an 
increase in type IIx-IIb hybrid fibers (p=0.02) and decreased in type IIb fibres (p=0.01) 
for AGE compared to the BSL (Figure 5.24). 
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Figure 5.23. EDL muscle fibre type CSA was measured for the BSL (n=6), AGE (n=6), 
and HFS-AGE (n=6). Data are reported as mean±SE *, signifies significant differences 
among groups for each fibre type. (A) The type IIa fibres of the HFS-AGE group was 
smaller than both the BSL (p=0.006) and AGE groups (p<0.0001). (B) The type IIa-IIx 
hybrid fibres of the AGE group were larger than both the BSL groups (p<0.0001). (C) 
The type IIx fibres of both the AGE and HFS-AGE group were larger than the BSL group 
(p=0.0005 and p=0.004, respectively). (D) The type IIx-IIb hybrid fibres of the HFS-
AGE group were smaller than both the BSL (p<0.0001) and AGE groups (p=0.02). (E) 
The type IIx fibres of the HFS-AGE group were smaller than both the BSL (p=0.004) and 
AGE groups (p=0.04). 
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Figure 5.24. EDL muscle fibre type composition was measured for the BSL (n=6), AGE 
(n=6), and HFS-AGE (n=6). Data are reported as mean±SE *, signifies significant 
differences among groups for each fibre type. There was an increase the proportion of the 
type IIx-IIb hybrid fibres for the AGE group compared to BSL (p=0.02) and for the type 
IIb fibres for the AGE group compared to BSL (p=0.01). 
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Ratios of Outcomes of Bone and Muscle 
Bone to Muscle Ratios Determined from Proximal Tibia and Soleus Measures 
The proximal tibia BV/TV to soleus peak tetanus decreased by 36% in AGE 
(p<0.05) and 32% in HFS-AGE (p<0.05) compared to BSL (Figure 5.25.A). The 
proximal tibia BV/TV to soleus CSA ratio decreased by 41% for AGE (p<0.01) and 45% 
for HFS-AGE (p<0.001) compared to the BSL (Figure 5.25.B). There were no 
differences among groups for proximal tibia BMD to soleus peak tetanus (Figure 5.25.C). 
Finally, for the ratio of proximal tibia BMD to soleus CSA there was a decrease (28%) in 
HFS-AGE compared to BSL (p<0.01) and no difference compared to AGE (p=0.07) 
(Figure 5.25.D). 
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Figure 5.25. The ratio of the BV/TV and BMD of proximal tibia to the peak tetanus and 
CSA of soleus was analyzed, BSL (n= 10), AGE (n=10), and HFS-AGE (n=9. Data are 
reported as mean±SE *, signifies significant differences between groups. (A) The BV/TV 
to soleus peak tetanus ratio decreased for the both the AGE (p=0.02) and HFS-AGE 
(p<0.05) groups compared to the BSL group. (B) The BV/TV to soleus CSA ratio 
decreased for the both the AGE (p<0.01) and HFS-AGE (p<0.001) groups compared to 
the BSL group. (C) There were no differences between groups for the BMD to soleus 
peak tetanus ratio. (D) The HFS-AGE group had a lower BMD:CSA ratio compared to 
the BSL (p<0.01). 
 
Bone to Muscle Ratios Determined from Proximal Tibia and EDL Measures 
The ratio of proximal tibia BV/TV to the EDL peak tetanus decreased for AGE (46%, 
p<0.01) and HFS-AGE (41%, p<0.05) compared to BSL (Figure 5.26.A). The proximal 
tibia BV/TV to EDL CSA decreased for AGE (39%, p<0.05) compared to BSL (Figure 
5.26.B). There was a decrease in the proximal tibia BMD to EDL peak tetanus ratio for 
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AGE compared to BSL (p<0.05) (Figure 5.26.C). As for the ratio of proximal tibia BMD 
to EDL CSA, there were no differences among groups (Figure 5.26.D).  
 
 
Figure 5.26. The ratio of the BV/TV and BMD of proximal tibia to the peak tetanus and 
CSA of EDL were calculated, BSL (n= 7), AGE (n=9), and HFS-AGE (n=9). Data are 
reported as mean±SE *, signifies significant differences between groups. (A) The BV/TV 
to EDL peak tetanus ratio decreased for the AGE (p<0.01) group compared to the BSL 
group. (B) The BV/TV to EDL CSA ratio decreased for the both the AGE (p=0.02) and 
HFS-AGE (p=0.03) groups compared to the BSL group. (C) The BMD to EDL peak 
tetanus ratio decreased for the AGE (p<0.05) compared to BSL group. (D) There were no 
differences among groups for BMD to EDL CSA. 
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Chapter 6: Discussion 
Summary of Main Findings 
 The present study takes a novel approach to studying aging male C57BL/6J mice 
beginning a HFS during middle aged (20 weeks of age) and combining both bone 
(trabecular structure, BMD) and muscle (grip strength, muscle contractile function, fibre 
typing) measures to analyze the effects of aging superimposed with a HFS. This 
comprehensive set of measures allowed novel ratios of bone and muscle to be analyzed. 
In addition, careful attention to diet composition was an important aspect to this study. 
One of the main findings of this study was that bone, measured as trabecular architecture 
and vBMD, had similar declines with aging regardless of diet, and HFS superimposed 
with aging had no further detrimental effect. Importantly, although soleus muscle of 
HFS-AGE had a greater structure (CSA), this did not translate to better function (force 
production). Therefore, although there was greater hypertrophy in soleus from HFS-AGE, 
this greater muscle size did not have the same contractile function (when normalized to 
CSA) compared to BSL or AGE, indicating that HFS-AGE potentially had metabolic 
disturbances resulting in poorer muscle function. Finally, in contrast to human [9] and 
mouse studies [132] that used different measures from the current study, bone to muscle 
ratios (regardless of differences in diet) declined with age as a result of a non-coordinate 
decline between the two tissues, with bone (BV/TV) having a greater rate of decline than 
muscle (peak tetanus and CSA). However, using BMD for these ratios (as in earlier 
studies) suggested a more coordinate decline in this ratio as has been previously reported. 
Previously the majority of bone to muscle ratios with aging have been calculated in 
humans using areal BMD or bone CSA as the bone measure, with either an increase in 
this ratio, suggesting a greater decline in muscle than bone, or no change, as reviewed by 
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[9]. The present study highlights that incorporating measures of trabecular structure, 
using BV/TV as the bone measure, captures the non-coordinate decline of bone to muscle 
with aging that may otherwise go undetected by using BMD measures. 
Mouse Characteristics 
Male C57BL/6J mice were used since they are an accelerated model for studying the 
effects of aging on bone and muscle and their age-related declines mirror similar 
alterations in bone and muscle with aging as humans [15, 131]. Using this model allows 
for longitudinal studies with tightly controlled diets and terminal experiments that are not 
otherwise possible in humans, such as whole muscle dissection for muscle function and 
morphology. 
HFS-AGE weighed more than AGE at the end of the 13-week diet intervention, 
which was expected since the HFS was more energy dense (4.6 kcal/g) than the control 
diet (3.6 kcal/g) resulting in an increased daily energy intake. In addition to this increased 
body weight, there was a shift in body composition with a decrease in lean mass and 
increase in fat mass in both groups, as expected this was more prominent in HFS-AGE 
compared to AGE. Therefore, AGE alone for 13 weeks caused a shift towards increased 
adiposity and decreased lean mass, even in the absence of a HFS, which mirrors changes 
in body composition in humans with aging [48]. Previously, alterations in body 
composition are associated with aging, with a continuous gain in fat mass over the 
lifespan in male C57BL/6J mice [98, 136]. As for diet-induced obesity, the shift in body 
composition has been well documented with similar experimental models using 12-week 
old male C57BL/6J mice (45% kcal fat lard and 173 g/kg sucrose for 11 weeks) [72], 9-
month old male C57BL/6J mice (60% kcal fat lard and 68.8 g/kg sucrose for 14 months) 
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[120], 4-week old male C57BL/6J mice (58% kcal fat coconut oil and 360 g/kg sucrose 
for 16 weeks) [137], and adult male Wistar rats (45% kcal fat lard and 223 g/kg sucrose 
for 16 or 24 weeks) [118]. With respect to bone mass, AGE had an increase and HFS-
AGE had a decrease in bone mass, but this does not necessarily confirm an alteration in 
total bone mass since body composition is measured as a relative percentage of total body 
mass. Therefore, it is suggested that these observed changes in body composition are 
likely because of a result of a loss in muscle mass and accumulation of fat mass with 
aging and diet-induced obesity [4]. The increase in absolute fat mass translates to an 
increase in the percentage fat mass and decrease in percentage lean mass as seen in the 
present study. 
Structure and BMD of Proximal Tibia 
Bone structure declined during the 13-week diet intervention for both AGE and HFS-
AGE and this was due to decreased Tb.Th and Tb.N and increased Tb.Sp resulting in an 
overall decline in BV/TV. This indicates that aging is a main contributor to the decline in 
bone structure since a HFS intervention in middle age had no further effect. For BV/TV, 
Tb.Th, and Tb.N there was an initial decline followed by a maintenance period, however, 
for Tb.Sp there was an initial increase for both AGE and HFS-AGE, but a maintenance 
period for HFS-AGE group and a decrease in Tb.Sp for the AGE group from 24 to 33 
weeks. Similarly, for BMD, there was an initial decline in both AGE and HFS-AGE 
groups, however there was a continued decline till the end of the study for both groups. 
For all proximal tibia measures there were no differences between AGE and HFS-AGE at 
any of the time points and both groups followed the same trend over time for all measures 
with the exception of Tb.Sp. These results were contrary to our hypothesis that AGE 
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group would have a steady decline in bone throughout the 13-week study, while HFS-
AGE group would initially be protected from this age-related bone loss due to the 
increased body weight with a decline in bone at the end of study.  
 The decline in bone structure and BMD with aging was unsurprising since it is 
well established that there is a decline in bone structure and mass with aging [3, 98]. 
Previously this decline in bone with aging has been shown in male C57BL/6J mice with a 
continuous decrement from 1.5 to 24 months of age. This decline was a result of a 
decrease Tb.N and an increase in Tb.Sp resulting in a decrease in BV/TV, however, 
unlike the current study there was little change in Tb.Th with aging [94]. Similarly, 
longitudinal assessment of bone structure from 1 to 20 months of age in male C57BL/6J 
mice highlighted that peak BV/TV occurs between 6-8 weeks of age and there is a steady 
decline thereafter, characterized by a rapid loss in Tb.N from 2 to 6 months of age [98]. 
This may explain the rapid loss in proximal tibia from 20 to 24 weeks of age with a 
slower decline until 33 weeks of age in the present study. Interestingly, some studies 
report an increase in Tb.Th with aging using adult (5 months) and old (23 months) male 
rats [97] or measuring male C57BL/6J mice across the lifespan (1 to 20 months of age) 
[98], however for both studies this increase in Tb.Th was not enough to maintain overall 
bone structure, since there was still a decline in BV/TV. Therefore, it appears that Tb.Th 
contributes less to the overall decline in bone structure and it is Tb.N and Tb.Sp that 
consistently alter BV/TV with aging. Although the relationship between aging and 
decline in bone has been well established, the effect of aging superimposed with a HFS 
has not been well investigated. Beginning a HFS diet in mice during middle age is unique 
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to bone literature with most studies beginning during growth and development [81, 82, 
84-86, 88] or young adulthood [72]. 
 The effects of diet-induced obesity on bone is controversial, with some research 
suggesting that the increased mechanical load as a result of obesity has a positive effect in 
male C57BL/6J mice [72] or no effect in female C57BL/6J mice [89], while other 
research suggests a negative effect as a result of increased bone resorption in male 
C57BL/6J mice [81, 82, 84-88]. This discrepancy in the response of bone to diet-induced 
obesity may be explained by differences in the age at which diet interventions begin. 
Young rodent models (4 to 7 weeks of age) that have not yet reached their peak bone 
mass are adversely affected by diet-induced obesity regardless of the diet duration (1 to 
18 months) [81, 82, 84-88]. Discrepancy in age and the effect of diet-induced obesity has 
specifically been tested with immature bone (5 weeks of age) compared to mature bone 
(20 weeks of age) being more adversely affected by a diet-induced obesity [85]. 
However, during young adulthood (12 weeks of age) once bone is fully matured but not 
yet undergoing age-related bone loss, it is suggested there can be a positive effect of diet-
induced obesity on bone [72]. The similar loss of trabecular bone in both AGE and HFS-
AGE in the present study suggests that diet-induced obesity has no positive effects 
inferred by the increased mechanical load and no further negative effects on middle age 
male C57BL/6J mice. Since the mice were fully matured they were not expected to 
experience the negative effects associated with diet-induced obesity during growth and 
development, but since they were older than the mice from the previous study that found 
positive effects of diet-induced obesity in young adult mice (12 weeks of age) [72] they 
were not expected to have positive effects on bone either. The increased mechanical load 
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inferred by increased body weight was not able to overcome the age-related decline in 
trabecular BMD or bone structure, however it also did not exacerbate the age-related 
bone loss as hypothesized. 
Both with aging and a HFD the cellular activity of bone marrow is altered to favour 
differentiation of mesenchymal stems into adipocytes instead of osteoblasts [64, 91]. In 
addition to favouring adipocyte differentiation, osteocytes become dysfunctional with 
aging, resulting in a progressive inability to sense forces [105], therefore the increased 
mechanical load as a result of diet-induced obesity may not have the same positive effects 
seen with adult male C57/BL/6J mice (12 weeks of age) [72]. However, testing a lifelong 
HFD using male C5BL/6J mice (3 weeks of age) fed a life-time (18 months) high fat 
westernized diet highlighted greater decline in trabecular bone compared to age matched 
controls [88] suggesting the a greater detrimental effect of a HFD over the lifespan [88]. 
Our data suggests that diet-induced obesity does not accelerate the loss of bone with 
aging during adulthood as exemplified by the same rate of trabecular bone loss in both 
the AGE and HFS-AGE groups. Previously, it had been hypothesized that diet-induced 
obesity works in two opposing phases, which includes an initial beneficial phase and a 
second phase that is detrimental with a lower bone formation rates [72]. This lead to our 
hypothesis that a HFS superimposed with aging would maintain bone structure and BMD 
for longer before age-related bone loss occurred, with potentially an increased 
detrimental effect of a HFS on bone as a result of alterations in cellular activity related to 
bone remodeling. Based on our results it appears that either the mice were at an age 
where there was no positive effect of the HFS on bone, but not old enough or on the HFS 
long enough for an additive detrimental effect with a HFS. Or, since the mice began the 
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HFS during middle age they may not have accumulated the negative effects associated 
with a HFS and bone.  
Grip Strength 
 Grip strength was used as a functional in vivo measure of muscle strength, 
however there was no differences between the AGE and HFS-AGE groups at any of the 
time points. There was a steady decline in four limb grip strength in both AGE and HFS-
AGE groups over the duration of intervention. It was difficult to achieve consistent 
measures for grip strength testing since there were issues with motivation to grip either 
the T-bar or grid with the mice, as a result measures two standard deviations above or 
below the mean were removed as outliers. Similar to our results a study comparing male 
C57BL/6J mice at 4 months, 18 months, and 24 months of age there were no changes in 
front limb grip strength [138], however, this study did not include aging superimposed 
with a HFD. In contrast to our front limb results but similar to four limb results, 
superimposing both aging and a HFD (60% kcal fat lard, 69 g/kg sucrose), using 8-month 
old male C57BL/6J mice, there was a significant decline in grip strength with a 5-month 
HFD compared to age matched controls [120]. This discrepancy could be a result of 
greater difficulties with the mice gripping the T-bar for front limb testing than the grid for 
four limb testing. 
Muscle Contractile Function 
This study investigated the effects of a long-term HFS on muscle function 
superimposed with aging, and it was hypothesized that high fat feeding would exacerbate 
the decline in muscle function associated with aging. Although it has been well 
established that there is a decline in muscle mass and strength with aging, the 
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combination of aging superimposed with a HFS and its effects on muscle function has not 
been well studied.  
Soleus 
Soleus muscle size was measured by CSA, which was greater when a HFS was 
superimposed with aging and there was a trend towards a larger soleus muscle even 
compared to younger baseline mice. However in contrast to our result, a study using 
middle aged male C57BL/6J mice (8-months of age) fed either a HFD or control diet for 
5 months, resulted in soleus atrophy only for the HFD group [120]. Lee et al, suggested 
that the soleus was more susceptible to the catabolic effects of a HFD since other muscle 
of fast/mixed fibre composition had similar rates of atrophy with aging regardless of diet 
[120]. This discrepancy may be due to differences in starting age, diet composition (e.g. 
source of fat, sucrose, adjusted vitamins and minerals), diet duration, and the 
interpretation of atrophy from soleus wet weight. [118]. However, our data suggests a 
different theory, since soleus is a postural muscle this greater CSA in HFS-AGE may be a 
result of the increase in body weight that would stress the soleus with ambulatory activity 
around the cage. This greater soleus CSA of the HFS-AGE was as a result of greater CSA 
of all the fibre types (I, IIa, I-IIa, IIb), which is in good agreement with previous work 
that reported greater CSA for soleus type I and IIa fibres with a HFD in 10 week old male 
C57BL/6J mice on a 60% HFD for 8 weeks [117]. The soleus CSA of the AGE did not 
differ from BSL, which was unexpected, and this may again be explained by differences 
in the starting age of our mice. However, immunohistochemistry showed that the AGE 
group had a decrease in type I and IIa fibres CSA, with no decrease for type I-IIa hybrid 
or IIb fibres CSA. These differences may be due to the cruder CSA measure compared to 
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the more sensitive muscle fibre type CSA or these changes in fibre CSA did not translate 
into a significant loss in whole muscle CSA in the time frame of our study. In contrast, a 
previous study using 6-month old male C57BL/6J mice reported no age-related decline in 
soleus fibre CSA, however this was not fibre type specific, and therefore specific fibre 
changes were likely missed [139].  
There was no alteration or shift in fibre type composition for soleus muscle 
among any of the groups. However, results from previous studies have been mixed, with 
no alteration in soleus type I or IIa fibres [117] or a significant decrease in type I fibres 
and no alteration in type IIa fibres with a HFD [121]. There is also a suggested shift in 
fibre type with aging, results from previous studies are contradictory with some results 
suggesting a shift towards type I fibres, others suggesting a shift towards type II, and 
many studies with ambiguous results, leaving the shift in fibre type with aging an 
unresolved research question [15]. Factors that contribute to the ambiguity in the 
literature include rodent strain, age, and gender, as well as staining techniques 
(immunohistochemistry that stains MHC isoforms or H&E staining) and measures of 
muscle size (mass or CSA). 
Although HFS-AGE had a larger CSA, this was not accompanied by increased 
muscle contractile function. Soleus twitch and tetanus force normalized to CSA was not 
altered between any of the groups, which is in line with previous results in younger male 
C57BL/6J mice (10 weeks of age) that found no change in relative force pre- and post-
fatigue with a HFD compared to a control group [117]. In addition, a study using both 
lard and palm oil as a fat source for a HFD (5 weeks) found only a decrease in peak 
twitch and tetanus force for palm oil, but not for lard in 12 week old male C57BL/6J mice 
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[116]. This differing effect of lard and palm oil may be due to differences in fatty acid 
composition with palm oil having greater palmitic acid (a saturated fat) than lard. Even 
though the mice used in these previous studies were young, the lack of muscle function 
decline in the middle aged animals used in the present study suggests that soleus muscle 
function declines at a later age. Although there were no differences among any of the 
groups for twitch or tetanus rate of force development there was a decreased tetanus rate 
of relaxation in AGE and HFS-AGE compared to BSL. Interestingly, there was an 
increase in twitch half relaxation in AGE and HFS-AGE compared to BSL, but no 
differences among groups for the tetanus half relaxation time, which has previously been 
shown with no alteration in twitch or tetanus half relaxation time with a HFD using lard 
as the fat source [116]. The contrast between the rate of relaxation and half relaxation 
time can be attributed to the differences in the measures, since rate of relaxation takes an 
average of the whole relaxation phase, while half relaxation is only a snapshot of muscle 
relaxation. Since Ca2+ handling determines relaxation, alterations in relaxation time 
suggest impaired Ca2+ uptake into the sarcoplasmic reticulum [116]. There was no shift in 
the force-frequency curves, which means that soleus force production was unaltered by 
aging or HFS across a span of frequencies. Previously, no differences in pre-fatigue 
force-frequency with a HFD have been reported, but post-fatigue there was a shift in the 
force-frequency curve resulting in less relative force at the same frequency in fatigued 
muscle [117]. No alteration in force-frequency with aging alone has also been reported in 
female mice across the lifespan [140], but in aged (26-27 month) male C57BL/6J mice 
greater force was produced at submaximal frequencies (10, 20, 30 Hz) compared to 
young (2-3 month) and middle aged (9-10 month) mice [114]. Finally, there was no 
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alteration in the maximum shortening velocity among any of the groups, but this was an 
unloaded shortening velocity therefore it only measured the ability of the fastest fibres to 
uptake slack. Since there was no major alteration in fibre type composition it is expected 
that there would be no change in the maximum shortening velocity. 
EDL 
As expected EDL muscle size measured by CSA decreased with aging, however 
superimposing a HFD with aging resulted in no alteration in CSA compared to younger 
baseline mice, suggesting that HFD reduced age related muscle wasting. Previously, 
middle aged mice (8 months of age) on either a 5 month HFD (60% kcal fat, lard) or 
control diet displayed similar decreases in muscle weight in mixed gastrocnemius, a 
mixed fast-twitch muscle, regardless of diet [120], whereas, our results suggest only 
atrophy of EDL with a control diet but not a HFD. This suggests that, like soleus, EDL of 
HFS-AGE was loaded more because of the increased body weight, slowing the rate of 
age-related muscle loss resulting in no differences in the EDL CSA between HFS-AGE 
and BSL. The only alteration in EDL fibre type composition was an increase in type IIx-
IIb hybrid fibres and a decrease in type IIb fibres in AGE compared to BSL, suggesting a 
potential shift towards more oxidative fibres with aging. Interestingly this shift towards 
oxidative fibres in gastrocnemius/plantaris muscles, seen as an increase in type IIa fibres 
and a decrease in type IIb fibres, has been reported in male C57BL/6J mice (10 weeks of 
age) fed a 8 week HFD (60% kcal fat, lard), but not for their age matched counterparts 
fed a control diet [117]. Therefore, the effects of diet-induced obesity in aging mice are 
not only muscle fibre type specific but also potentially also age-specific since the animals 
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used in this study were mature adults compared to previous studies that have used young 
animals.  
Unexpectedly, the individual fibre type CSA data did not support the alterations 
in whole muscle EDL CSA for AGE and lack of alteration for HFS-AGE group 
compared to BSL. The type IIa fibre CSA decreased in HFS-AGE, while AGE 
maintained its type IIa fibre CSA compared to BSL. Interestingly, the type IIa-IIx hybrid 
fibre CSA were much larger in AGE compared to both BSL and HFS-AGE while the 
type IIx fibre CSA increased in both AGE and HFS-AGE compared to BSL. The type 
IIx-IIb hybrid and type IIb fibres both followed the same pattern with a decrease in CSA 
in HFS-AGE compared to BSL and AGE. As mentioned above, it has previously been 
reported that there is no alteration in gastrocnemius muscle wet weight with a HFD, 
however in contrast to our results this study also found a decrease in gastrocnemius fibre 
CSA with a HFD but not aging [120]. In a study using young male C57BL/6J mice (10 
weeks of age) there was no alteration in any fibre CSA for faster-twitch 
gastrocnemius/plantaris muscles for either a 8-week HFD or control diet [117]. This 
discrepancy between muscle CSA or wet weight with fibre specific CSA may be due to 
overall decreases in fibre number and not fibre CSA, since not every muscle fibre CSA is 
measured. It is important to note that muscle wet weight and CSA, which is calculated 
using muscle wet weight, are less accurate measures of alterations in muscle morphology 
since muscle is composed of many components including contractile proteins, collagen, 
lipids, and water, whereas fibre CSA is a more direct measure of muscle morphology. 
Therefore, the decrease in EDL CSA was not as a result of a decrease in fibre CSA and 
discrepancies with other studies may be due to the comparison of EDL to the 
	   	   86	  
gastrocnemius and plantaris muscles, even though they are both hind limb fast-glycolytic 
muscles like EDL. Both the gastrocnemius and plantaris muscles have a greater 
composition of type IIx fibres and less type IIb fibres compared to the EDL [110]. 
EDL peak twitch force and twitch rate of force development was greater in AGE 
and HFS-AGE compared to BSL, suggesting improved muscle function with aging or 
HFS.  This is in contrast to previous research that demonstrated EDL peak tetanus force 
did not improve from young (2-3 months) to adult (9-10 months) male C57BL/6J mice 
[114]. The discrepancy may be explained by experimenter inexperience at the time of 
baseline experiments, with EDL peak tetanus <200mN being considered unviable. As for 
peak tetanus force and tetanus rate of force development there were no differences among 
any of the groups. As for rate of relaxation both AGE and HFS-AGE had a lower rate of 
relaxation compared to BSL for both twitch and the tetanus, but no alteration in half 
relaxation time for twitch or tetanus. In contrast to our results, 12-week old male 
C57BL/6J mice on a 5-week high fat (45% kcal, lard or palm oil) and sucrose (173 g/kg) 
resulting in diet-induced obesity did not have any alterations in twitch or tetanus peak 
force or contraction time, but there was an increase in twitch relaxation time but not 
tetanus relaxation time with a HFD [116]. The difference in the age of the animals and 
duration of the diets would explain these differential results, suggesting that the older 
animals used in this study on the longer duration HFS have greater detriments in muscle 
function. In addition, it is possible that EDL BSL measures had methodological errors, 
since there was a lack of experience performing muscle function experiments there were 
difficulties with EDL in vitro testing resulting in low force production (muscle with a 
peak tetanus <200 mN were removed). Therefore, future work will require ordering 
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another set of age-matched BSL animals to repeat some of these measures and reconcile 
these issues. 
Although there was no shift in maximum unloaded shortening velocity, there was 
a leftward shift in the EDL force-frequency curve for AGE and HFS-AGE, meaning that 
in these groups a greater force is generated at lower frequencies of stimulation. This is 
consistent with our observation that AGE and HFS-AGE produced greater twitch force, 
but not tetanus force. An increase in relative force at lower frequencies has been reported 
post-fatigue, but not pre-fatigue with a 8 week HFD in 10-week old male C57BL/6J mice 
[117], for aged female C57BL/6J mice (27-28.5 months) [140], and aged (26-27 months) 
male C57BL/6J mice [114]. Therefore, aging causes a shift in the force-frequency curve 
pre-fatigue, but it is unknown how aging would shift the force-frequency curve post 
fatigue. 
Ratios of Outcomes of Bone and Muscle  
 Since aging is associated with both a loss in BMD and strength, referred to as 
osteoporosis, and a loss in muscle mass and strength, referred to as sarcopenia, it is 
important to study both these tissues together. The mechanical relationship between bone 
and muscle, specifically the force exerted from muscle contraction on bone, is suggested 
to regulate BMD and strength to muscle forces. It is Wolff’s law that describes bone 
plasticity and how bone changes its shape and structure to match mechanical loads [141] 
and the mechanostat theory states that muscle is a primary source of mechanical loading 
on bone [12, 130]. The association of muscle CSA of the forearm and radius bone size 
supports this relationship, which is a non-weight bearing site in humans and the 
association between muscle CSA and bone size is stronger than that of body weight or fat 
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mass [9]. Since there is an established mechanical relationship between bone and muscle, 
it is suggested that there is a ratio of bone to muscle properties including size and 
strength. These ratios have been investigated in humans using BMD or bone CSA to 
muscle force, muscle CSA, or lean mass (arm or leg), with many studies finding an 
increase or no change in this ratio with aging (reviewed in [9]). Similarly, comparing 
male C57BL/10 mice at 7 week and 24 month of age, there was no alteration in the bone 
to muscle ratio with aging, measured as tibia mid-diaphysis ultimate load to EDL peak 
tetanus force normalized to muscle CSA [132]. However, there is limited research 
studying this relationship in animal models, with other studies examining the effects of 
estradiol [142] or running and estradiol [143]. Together, these findings suggest no 
alteration in the bone-to-muscle ratio and have been used as evidence of a coordinate 
decline in these two tissues with aging. 
The ratio of bone-to-muscle measures in this study suggested little to no 
alterations in this ratio when BMD to either peak tetanus or CSA for both soleus and 
EDL were used, which fits with previous literature [9, 132]. However, when BV/TV to 
both peak tetanus or CSA for both soleus and EDL are used, there is a decrease in the 
bone-to-muscle ratio with aging regardless of diet. Previously, the bone-to-muscle ratio, 
measured using peak isometric force (EDL) to bone strength (ultimate load of tibia mid-
diaphysis), has shown no alteration with aging, comparing 7 week and 24 months old 
wild-type C57BL/10 male mice [132]. Although this study reported no alteration in the 
ratio of bone-to-muscle, using bone strength testing only measures the cortical bone and 
not trabecular bone, and therefore our results highlight the differences in measures used 
to calculate this ratio, BMD versus BV/TV.  
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Strengths 
 The primary goal of this study was to investigate how bone and muscle structure 
and function are affected by aging superimposed with a HFS. To achieve this goal, mice 
from the same batch were ordered in to reduce any variations among the animals since 
there were endpoint surgeries at BSL and following the 13-week intervention. Modeling 
the HFS from the standard AIN93-M diet ensured that the diets were as similar as 
possible; the lard used for the HFS diet was also tested for vitamin D content to adjust 
diets accordingly. In addition, micronutrients (e.g., calcium, phosphate, and vitamin D) 
were matched for energy since the HFS had a higher energy level by weight, to isolate the 
effects of diet-induced obesity. Aside from the HFS, the AIN93M diet was used as the 
control diet instead of standard chow since it is a semi purified diet with consistent 
composition. Food intake and body weight were tightly tracked by taking these measures 
three times a week to reduce variations in this measure. The major strength of this study 
was the combination of analyzing bone and muscle simultaneously with the 
superimposition of aging and diet-induced obesity, since these tissues have traditionally 
been studied separately. The longitudinal in vivo measurements of bone structure, vBMD, 
and body composition were measured in the same mouse throughout the study, reducing 
variation and allowing for direct determination of changes during the life-course studied. 
As well, using µCT for these measures allowed for very precise bone measures. The 
combination of grip strength and excised muscle contractile function provided both a 
functional measure of neuromuscular strength and contractile properties, respectively. 
Muscle immunohistochemistry provided explanation for alterations in muscle contractile 
function. This comprehensive set of bone and muscle measures allowed for a thorough 
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analysis of alterations in bone and muscle with aging and aging superimposed with a 
HFS. 
Limitations 
Since the mice used in this study were fully matured, alterations in bone were most 
likely less substantial compared to that of immature growing mice. As a result, a longer 
diet intervention or beginning the diet at a younger age may have highlighted differences 
between aging and aging superimposed with a HFD. Another limitation was an issue with 
the µCT during scanning, which resulted in the 8-week scans being removed from the 
data set. As for muscle function testing there were difficulties with the EDL in vitro 
testing system and the experimenter was inexperienced at the time of baseline 
experiments resulting in greater variability in the measures in this group. In addition, grip 
strength testing was a new measure within the lab and the measure was very variable as a 
result of the mice not gripping either the T-bar or grid. Mineral apposition rate was not 
included in this thesis, which would provide a snapshot of the rate of bone formation and 
resorption. Future studies should study both sexes to better understand how aging and 
aging superimposed with diet-induced obesity affects the musculoskeletal system since 
male and females have different hormonal responses especially with aging.	  
Conclusions 
Hypothesis	  1:	  The aging group will have a steady decline in bone structure and BMD 
throughout the 13-week study, while the group fed obesogenic diet (HFS-AGE) will 
initially be protected from the age-related bone loss due to increased body weight, but 
would have an exacerbated decline in bone structure and BMD at older ages. 
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Consistent with the hypothesis, aging resulted in a steady decline in bone 
structure and BMD throughout the 13-week study. However contrary to the hypothesis a 
HFS superimposed with aging did not protect adult male mice from age-related bone loss 
at the beginning of the study and also did not result in an exacerbated decline in bone 
structure or BMD by the end of 13-week diet intervention. Therefore, adult male mice 
beginning a long-term HFS at 20-weeks of age undergo age-related bone loss at the same 
rate as age matched controls. At first glance this does not appear consistent with the 
hypothesized inverted ‘U’ shape curve, however the mice did not experience any positive 
effects with the HFS since they were older adults at 20-weeks of age. But, they also did 
not have an exacerbated decline in bone structure and BMD as expected, perhaps because 
they were not aged out on the HFS long enough. Therefore, this data expands what is 
currently known about the inverted ‘U’ shape hypothesis, as it appears that there is a 
neutral period during which a HFS does not have either a positive or a negative effect on 
bone structure and BMD. 
Hypothesis	  2:	  The aging group would have a decline in muscle function compared to the 
baseline group, while the HFS superimposed with aging group would have an 
exacerbated decline in muscle function associated with aging as a result of disruptions in 
muscle signaling. Specifically, the soleus force production and EDL relaxation time 
would be negatively impacted by the HFS. 
Soleus and EDL differentially responded to aging and aging superimposed with a 
HFS. Soleus muscle had hypertrophy with a HFS, which could be an adaptation to the 
increase in body weight since it is a postural muscle, whereas EDL did not have any 
hypertrophy but also did not undergo muscle wasting with a HFS during aging. Contrary 
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to the hypothesis soleus rate of relaxation and half relaxation time but not force 
generation was negatively impacted with aging and aging superimposed with a HFS, 
whereas EDL had slower rate of relaxation and improvements in force generation and 
rate of force production, which is most likely a result of issues during baseline measures. 
Hypothesis 3: The ratio of bone to muscle will be constant in the aging group, indicating 
that these two tissues decline in a coordinate manner. Although the ratio of bone to 
muscle will also remain constant in the high fat diet superimposed on aging group, this 
would be a result of both the bone and muscle structure and function being negatively 
affected to a similar extent by a high fat diet in aging animals. 
The present study found that bone and muscle do not decline at the same rate with 
aging regardless of diet in adult male C57BL/6J mice, which was a result of a greater 
decline in bone structure than muscle function or size. This was supported by the ratios of 
BV/TV to both peak tetanus or muscle CSA, however relationship did not hold when 
BMD was used as the bone measure, reinforcing that BV/TV is a more sensitive measure 
that captures alteration in bone that would otherwise potentially be missed just using 
BMD.  
Significance  
 The two greatest aspects affecting musculoskeletal health are aging and the 
obesity epidemic, which makes it an integral area of research to understand the effects of 
this dichotomy. This study was a comprehensive investigation of bone (bone structure, 
and BMD) and muscle (functional contractile strength, contractile properties, and fibre 
type) to study the ratio of change between bone and muscle quality and quantity with 
aging superimposed with a HFS. Our data suggests that bone declines at a greater rate 
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than muscle regardless of diet or the lack of alteration in the mechanical influence of 
muscle contraction on bone. Based on our results and the literature this indicates that the 
timing of diet intervention is integral, with less positive effects observed during growth 
and development, positive effects during young adulthood, and a lack alteration in the 
rate of decline bone during later adulthood in male C57BL/6J mice as observed in the 
present study.  
Future Directions 
 Further analysis will be completed for bone histology to measure the mineral 
apposition rate. This analysis will provide information on the rate of bone formation and 
resorption as an indirect measure of osteoblast and osteoclast activity at the end of the 13 
weeks. Future studies should continue to explore the relationship between bone and 
muscle across the lifespan with obesogenic diet interventions. This is important for 
expanding research investigating critical time points for nutrition and how the 
musculoskeletal system is affected. Since muscle and bone is integrally linked it is 
critical to study these tissues in conjunction 
To explore this relationship a life-long HFS into senescence should be used, 
terminating animals in varying life stages (e.g. 6 weeks, 20 weeks, 34 weeks, 48 weeks, 
and 62 weeks). Using magnetic resonance imaging both bone and muscle can be 
measured longitudinally to track bone structure, muscle CSA, and body composition, 
along with BMD using dual energy X-ray absorptiometry at 2-week increments. Mineral 
apposition rate would also be measured by injecting calcein and alizarin markers 7 and 2 
days prior to euthanasia. Muscle function testing measures would include peak twitch 
force, peak tetanus force, rate of force development, rate of relaxation, half relaxation 
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time, and force-velocity curve (which was missing from the current investigation). Fibre 
type would also be analyzed to track alterations in fibre composition and fibre CSA. 
Again a focus would be on the ratio of bone-to-muscle using both BV/TV and BMD as 
bone measures and peak tetanus and CSA as muscle measures. This study would help to 
better understand the hypothesized inverted ‘U’ associated with a HFS on bone and 
incorporate muscle function to associate mechanical load with alterations in bone. A 
follow up study to extending a HFS over the lifespan would be to begin a high fat diet at 
different stages of life (e.g. 6 weeks, 20 weeks, 34 weeks, 48 weeks) with measures 
mentioned above. The combination of these two studies would address the discrepancies 
in the literature. Future work should also investigate how animal models mimic aging and 
aging superimposed with HFS in humans in both bone and muscle to better interpret 
findings from previous research. 	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Appendix I: 
Project Outcomes 
 
Outcome  Description 
µCT Body Composition Measure of relative lean mass, fat mass, 
and bone mass 
µCT Bone Measures  
BV/TV Ratio of segmented bone volume to total 
volume of the region of interest (%) 
Tb.Th Mean thickness of the trabecular struts 
(mm) 
Tb.N Measure of the average number of 
trabecular struts per unit length (mm2) 
Tb.Sp Mean distance between trabecular struts 
(mm) 
BMD Measure of the density of bone within the 
region of interest (g/cm3) 
In vivo Grip Strength Measure of neuromuscular function and 
functional measure of muscle strength by 
determining the maximal peak force 
produced by a mouse (front limb or all four 
limb) 
Muscle Function  
Cross-sectional Area (CSA) Measure of muscle CSA (mm2) 
Peak twitch force Measure of the maximum force from a 
twitch (mN) 
Peak tetanus force Measure of maximum force from a tetanus 
(mN) 
+df/dt Rate of force production  (mN/ms) 
-df/dt Rate of relaxation (mN/ms) 
Half relaxation time Time of half the tetanus maximal force 
(ms) 
Maximum unloaded shortening velocity Velocity calculated from the time it takes 
the muscle redevelop tension after a set 
change in muscle length (fibre lengths/s) 
Force frequency curve Plotting the maximum force through a 
range of frequencies  
Fibre typing Staining muscle cross-sections for the 
different myosin heavy chains (type I, IIa, 
IIx, and IIb) 
Bone to muscle ratios Measure of bone (proximal tibia BV/TV or 
BMD) to muscle (soleus and EDL peak 
tetanus and CSA) 
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Appendix II: 
Micro-computed Tomography  
 
Setting up the Micro-computed Tomography (µCT) System 
1. Open SkyScan program and turn on the X-ray, allow X-ray to warm up for 10-15 
minutes 
2. Complete flatfield  
• Options à scanner setup (might have to click crtl+alt+shift+s to unlock), 
select scanning parameters: 
Body scanning parameters: 40 kilovolts and 200 microamps, with a 430 millisecond 
exposure time and a rotation step of 0.8° 
Leg scanning parameters: 40 kilovolts and 200 microamps, with a 430 millisecond 
exposure time and a rotation step of 0.7° 
3. Scout Scan 
• Scout scan to view 
Reconstruction 
1. Open NRecon program 
2. Open image file and set up reconstruction parameters (see chart below) 
3. To batch reconstruct files choose ‘add to batch’ following setup 
4. Once all bone have been setup and added to batch choose ‘start reconstruction’ 
Reconstruction parameters for in vivo leg and body scans using NRecon program. 
 In vivo leg scans In vivo body scans 
Beam hardening 40% 30% 
Ring artifact 8 8 
Smoothing 4 8 
Dynamic threshold 0.0 – 0.110 0.0 – 0.056 
 
Reorientation 
1. Open Dataviewer program 
2. Reorientate each sample by holding ‘ctrl’ key while using mouse to move bone in 
the x, y, z image planes 
3. Reorientate the bone as straight as possible in the x and y planes  
4. Save the transaxial plane as dataset 
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Region of Interest 
1. Open CTan program 
2. Open reoriented file 
3. Set region of interest at either end of slice selection 
• For proximal tibia set an offset of 30 slices from the end of the growth 
plate with a 60 slice region of interest 
• For body scans identify the very beginning and end of the third lumbar 
vertebra   
4. Save the region of interest 
 
Analysis 
1. Open CTan program 
2. Open ROI file 
3. Run analysis with task list 
In vivo leg scan proximal tibia analysis task list. 
Task List Parameters 
Thresholding low 90, high 255 
Despeckle sweep, all except largest, image, 3D space 
ROI shrink wrap shrink wrap, 2D space 
Bitwise operations image = NOT image 
Bitwise operations image = image & ROI 
Morphological operations opening, round image, 2D space, radius=2 
Despeckle sweep, all except largest, image, 3D space 
Morphological operations closing, round, image, 2D space, radius=10 
Morphological operations opening, round image, 2D space, radius=10 
Morphological operations erosion, round image, 2D space, radius=3 
Morphological operations dilation, round image, 2D space, radius=2 
Bitwise operations ROI = ROI sub image 
Reload image 
Save bitmaps image inside ROI, BMP, copy dataset to 
log files 
Save bitmaps ROI, BMP, convert to monochrome 
Thresholding low 90, high 255, copy dataset to log file 
ROI shrink wrap shrink wrap, 2D space 
Structure  2-D analysis 
BMD histogram 
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Appendix III: 
Muscle Contractile Experiments 
 
Setting Up the In Vitro Apparatus 
1. After turning on the computer, open the single channel data collection program 
2. Open ‘Set Up’, ‘Protocol’ and ‘Scope’ windows 
3. Switch ASI stimulator and servomotor/force transducer control units ON 
4. Zero the force in signal by clicking ‘Record Fin’ in ‘Set Up’ window periodically 
until the value stabilizes around a given number (usually 27-32 mV)  
5. Pour Tyrode’s solution into bath 
6. Turn Circulator ON  
7. Turn oxygen using master valve on gas cylinder, and adjust air flow into vertical 
organ bath using fine black adjustment knobs to obtain a steady stream of bubbles 
Surgical Procedures 
1. Place mouse in chamber for anesthetic induction at 5% isoflurane 
2. Once mouse is under transfer to nose cone and maintain isoflurane between 2-5% 
3. Begin procedures once the pedal reflex is absent 
4. Remove skin to expose hind limb musculature 
5. Isolate TA tendon, and remove TA 
6. Stop bleeding associated with removal of TA using Kimwipe  
7. Isolate EDL and tie non-absorbable silk sutures to the proximal and distal tendons 
of the EDL 
8. Place muscle in intermediate bath before mounting muscle in vertical organ bath 
9. Isolate Achilles tendon and cut through calcaneus bone being careful not to cut 
the tendon 
10. Isolate the soleus and tie non-absorbable silk sutures to the proximal and distal 
tendons of the soleus 
11. Place muscle in intermediate bath before mounting muscle in vertical organ bath 
 
Mounting Isolated Muscles 
1. Zero Fin 
2. Open bottom clamp 
3. Loop top suture onto servomotor lever arm 
4. Straighten bottom suture and insert into bottom clamp 
5. Tighten bottom clamp 
6. Adjust muscle length using adjustment knob until muscle is taut (3-5 mN) and 
lock in place 
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Muscle Function Experimental Setup 
1. Input reference length (soleus 12mm and EDL 11 mm) 
2. Load equilibration sequence in Sequencer view of Protocol window 
3. Enable Slip Tetanus protocol to check for suture slippage 
4. Enable Equilibration protocol  
5. Following Equilibration protocol or until muscle consistently produces same 
force, enable Optimal Length protocol 
6. Determine the resting tension at which the largest active force is produced (i.e., 
total tension – passive tension) 
7. Set muscle length to resting tension that best represents Lo 
8. 7. Use digital venire calipers to measure the new length, input as Reference 
Length and record Lin 
9. Begin experimental protocol 
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Appendix IV: 
Muscle Histology Mounting 
 
Muscle Mounting 
1. Prepare cork sections (1X1) large enough to fit muscle sample and label both 
sides 
2. With liquid nitrogen in liquid nitrogen container, cool the 2-methyl butane in the 
metal bowl (-155°C) 
3. Listen for first and second sizzle of 2-methyl butane; the inner area of the metal 
bowl should become white and slushy 
4. Place blob of Cryomatrix embedding compound in the center of the cork and dip 
into the cooled 2-metyl butane until it begins to freeze along perimeter, continue 
process to build ‘tower’ with perimeter frozen and center unfrozen 
5. Orient muscle section in the center of the Cryomatrix embedding compound as 
vertical as possible with muscle fibres perpendicular to the cork 
6. Add extra Cryomatrix embedding compound to ensure the muscle is completely 
covered 
7. In one swift motion invert the set sample and drop into the cooled 2-methyl 
butane for 30-90 seconds 
8. Wrap sample in tin foil (labeled on both sides) and store sample at -80°C until 
slicing. 
Protocol: Muscle Slicing 
1. Cool cryostat to -22°C 
2. Equilibrate muscle samples in cryostat for approximately 20 minutes 
3. Slice samples at 10µm thickness 
4. Adjust blade and glass antiroll plate as needed 
5. Slice 4-6 transverse sections per microscope 
6. Store slides at -80°C until staining 
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Appendix V: 
Muscle Immunofluorescence Fiber Typing 
 
Procedure: 
1. Air dry slides for 10 minutes at room temperature. 
2. Incubate sections for 1 hour in blocking solution: 10% goat serum in 1 x PBS 
(100µL/slide) at room temperature on shaker. 
3. Blot dry slides avoiding muscle sections. 
4. Incubate sections in 1˚ antibodies appropriately diluted in blocking solution for 1 
hour (100µL/slide) at room temperature on shaker. Give the stock antibody tubes 
a quick shake/inversion before pipetting out of them to make 1˚ antibody cocktail. 
• MHCl (BA-F8) @ 1:50 – IgG2b: blue 
• MHClla (SC-71) @ 1:600 – IgG1: green 
• MHCllb (BF-F3) @ 1:100 – IgM: red 
5. Wash slides 3 x 5 minutes in a Columbia jar with 1 x PBS. 
6. Blot dry slides avoiding muscle sections. 
7. Incubate sections in appropriate 2˚ antibodies diluted 1:500 in blocking solution 
for 1 hour at room temperature in the dark on shaker. Ensure as little light as 
possible makes contact with the 2˚ antibodies and sections from this point 
8. Wash slides 3 x 5 minutes in a Columbia jar with PBS. 
9. Apply 15µL of Prolong to each slide and mount with a number 1 coverslip. The 
coverslip can be pressed gently to remove bubbles, but do not apply pressure 
direction above sections, they will squish. 
10. Tack the corners of the coverslip down with nail polish and place in a labeled, 
lightproof slide box. 
11. Slides should be imaged no longer than 2 days after staining, next day imaging 
seems to work best once Prolong gold has set. 
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Appendix VI: 
Grip Strength Testing 
 
Grip strength testing allows for the measure of neuromuscular function by 
determining the maximal peak force developed by a rodent (mouse or rat). In vivo grip 
strength testing is a functional measure of muscle strength and is a quick, repeatable 
measure.  
Procedure 
1. While the Bioseb Grip Strength Meter is turned off, set up the desired attachment 
(T-bar or grid) depending on the grip strength measure (e.g. front limb or all four 
limbs) 
2. Once the system is set up, turn it on and tare the instrument by pressing the ‘zero’ 
key. 
3. Hold the mouse by the base of the tail above the T-bar or grid depending on the 
measure 
4. Move the mouse down until the front limbs or all four limbs grab the T-bar or grid  
5. While the mouse is grasping, lower its position to a horizontal position and gently 
pull following the axis of the sensor until the grip is released 
6. Record the maximum force displayed on the screen. 
 
 
Notes 
• Repeat all measures in triplicate. 
• Gently pull mice or rats in one smooth motion with no abrupt movements. The 
goal is to get a constant velocity movement to insure repeatable measures. 
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Appendix VII: 
Bone to Muscle Outcome Ratio Calculations 
 
Bone to muscle outcome ratios were calculated using BV/TV as a representative 
measure of trabecular structure and vBMD as a measure of bone quantity for this study, 
and soleus and EDL peak tetanus force was selected as a representative measure of 
muscle contractile function. In addition, CSA was used as a measure of muscle quantity. 
Ratios included vBMD:CSA, vBMD:peak tetanus, BV/TV:CSA, and BV/TV:peak 
tetanus. 
 
The AGE and HFS-AGE bone measures (BV/TV or vBMD) were divided by muscle 
measures (peak tetanus or CSA) within each animal. Since BSL had no measure for 
trabecular bone, the average from baseline measures (BV/TV and vBMD) from AGE and 
HFS-AGE was used respectively (variation between animals for bone measures prior to 
interventions was extremely low with no significant difference between groups) 
 
Sample Calculation 
 BV/TV vBMD Soleus peak 
tetanus 
Soleus CSA 
C6-blank 7.28% 
 
0.199 g/cm3 
 
208 mN 
 
2.03 mm2 
 
 
Ratio = BV/TV / peak tetanus 
= 7.28/ 208 
= 0.035 
 
Ratio = BV/TV / CSA 
= 7.28/ 2.03 
= 3.59 
 
Ratio = vBMD / peak tetanus 
= 0.199/ 208 
= 9.6 x 10-4 
 
Ratio = vBMD / CSA 
= 0.199/2.03 
= 0.098 	  
